{
  "name" : "dacemirror.sci-hub.se_journal-article_ba02a01f9b399be3997e6c8f8922011f_li2016.pdf",
  "metadata" : {
    "source" : "CRF",
    "title" : "Nano carriers for drug transport across the blood–brain barrier",
    "authors" : [ "Xinming Li", "John Tsibouklis", "Tingting Weng", "Buning Zhang", "Guoqiang Yin", "Guangzhu Feng", "Yingde Cui", "Irina N. Savina", "Lyuba I. Mikhalovska", "Susan R. Sandeman", "Carol A. Howel", "Sergey V. Mikhalovsky" ],
    "emails" : [ ],
    "sections" : [ {
      "heading" : null,
      "text" : "ARTICLE HISTORY Received 2 November 2015 Revised 28 March 2016 Accepted 12 April 2016 Published online 20 May 2016\nKEYWORDS Blood–brain barrier; drug delivery; nanomaterials"
    }, {
      "heading" : "Introduction",
      "text" : "The increasing incidence of cerebral diseases as a result of the worldwide aging population demands the urgent development of therapeutic, diagnostic and preventive agents. While brain drug development has been limited, owing to the restrictive transport properties of the blood–brain barrier (BBB), which is a unique regulatory system of brain capillaries that protects the brain environment by preventing most molecules in the blood stream from entering the central nervous system (CNS) [1–6]. Thus, unlike other organs in the human body, more than 98% of small molecules, and nearly, 100% of large therapeutic molecules cannot reach brain via the circulatory system [7].\nOne strategy for brain drug delivery is bypassing the BBB using highly invasive methods, such as intracerebral and intracerebroventricular administration [8,9], or noninvasive methods such as intranasal delivery. Another strategy is blood-to-brain delivery via circulatory system as a result of transient BBB disruption induced by biological, chemical or physical stimuli such as zonula occludens toxin, mannitol, magnetic heating and ultrasound [10–13]. These brain drug delivery strategies have not been widely used because they are risky, costly or unsuitable for less localized brain diseases [14].\nThe strategy of blood-to-brain delivery that involves improving BBB permeability of drugs or drug–carrier conjugates under normal\nconditions can minimize the above-mentioned side effects. One approach is to modify the chemical structure of drugs; so far only one drug has been successful: the conversion of morphine to heroin [15,16]. By coupling drugs with various brain nutrients or growth factors, such nutrients/growth factors-mediated delivery showed another promising approach to improve BBB permeability of brain drugs, as specific transporter proteins for brain nutrients/ growth factors on the membrane of brain capillary endothelial cells can also facilitate the transfer of some nutrient/growth factor–drug conjugates by means of transcytosis [17,18]. Unfortunately, this approach is also of little value because only a small number of drugs can be converted to nutrient/growth factor–drug conjugates.\nNanomaterials are submicrometre objects that behave as a whole unit in terms of their transport and properties; it has been found that nanomaterials can internalize into most cells (including brain capillary endothelial cells) by means of normal endocytosis and transcytosis due to ‘‘nano effects’’ as a result of their small size [19]. Consider their possibility of being functionalized with multiple copies of the drug molecule of interest, widespread drug delivery to the brain via the transvascular route through the intact BBB by using nanomaterials as a carrier vehicle which can be dubbed ‘‘Molecular Trojan Horse’’ is possible [20–23]. Nanomaterials have been widely investigated for brain drug delivery; in this review paper, we discuss various forms of nanomaterials for blood-to-brain drug delivery through the intact BBB; the mechanisms of\nCONTACT Xinming Li lixinming@sina.com School of Chemistry and Chemical Engineering, Zhongkai University of Agriculture and Engineering, No.24 Dongsha Street, Haizhu District, Guangzhou 510225, Guangdong, China 2016 Informa UK Limited, trading as Taylor & Francis Group\nnanomaterials-mediated drug transport across the BBB; and the future directions of this innovative area of research.\nNano carriers for drug transport across BBB\nDepending on the method of uploading, therapeutic, diagnostic or preventive molecules can be dissolved, entrapped, adsorbed, encapsulated or covalently attached to nanomaterials, to give nano-sized drug–carrier conjugates in the forms of nanoparticles, liposomes, micelles, nanogels, nanoemulsions, quantum dots, dendrimers, exosomes and polymersomes. These objects are in the nanometer (1–1000 nm) size range differing markedly from items made of identical materials in the terms of properties and functions. With the minimal diameter of blood capillaries being 6–9 lm, nano-sized drug–carrier conjugates hold the capability to reach organs via bloodstream. The average size of cells in the human body is 10–20 lm; thus, adsorption or uptake of the nano-sized drug–carrier conjugates by cells is possible, providing an opportunity to deliver drugs into cells. With the possibility of being surfacely functionalized with targeting ligands, nano carriers offer the capability of transporting drugs across the BBB."
    }, {
      "heading" : "Inorganic nanoparticles",
      "text" : "Nanoparticles from inorganic materials, such as silica, carbon, metal or metal oxide, are solid nano-sized particulate objects that have been widely used in imaging techniques [24]. Inorganic nanoparticles are of stable size and form mono-disperse suspensions in body fluids; their surfaces can be functionalized to facilitate BBB penetration. With high surface area, large pore volume, good biocompatibility and ease of functionalization, mesoporous silica nanoparticles have been conjugated with poly(ethylene glycol) (PEG) for BBB penetration as a result of their improved hydrophilicity, the eliminated aggregation in the blood stream, as well as the minimized clearance by the reticuloendothelial system (RES) [25]. The fluorescein-doped magnetic silica nanoparticles (FMSNs) incorporating therapeutic molecules have been covalently conjugated with the second-generation (G2) PAMAM (polyamidoamine) dendrimers through 3-(triethoxysilyl) propyl isocyanate (ICP) to yield PFMSNs, followed by the reaction with tresylated MPEG (methoxypolyethylene glycol)-5000 to yield PEGylated PFMSNs. It has been found that PEGylated PFMSNs could penetrate the intact BBB through transcytosis of vascular endothelial cells, with subsequent diffusion into the cerebral parenchyma and distribution in the neurons. In contrast, non-PEGylated FMSNs were not found to cross the BBB, which showed PEG modification on the surface of the silica nanoparticles may offer an opportunity to cross the BBB.\nSimilar to PEG-modified silica nanoparticles, PEG-modified carbon nanotubes (CNTs) also exhibited the capability of crossing the BBB. CNTs have ultrahigh surface area that permits efficient loading of multiple molecules alongside the nanotube wall, and the supramolecular binding of aromatic molecules such as doxorubicin (DOX) can be easily achieved by p–p stacking of those molecules onto the polyaromatic surface of nanotubes. Oxidized multiwalled carbon nanotubes (O-MWNTs) uploaded with DOX have been conjugated with PEG and angiopep-2; the results of intracellular tracking in vitro and fluorescence imaging in vivo demonstrated that the combination of O-MWNTs-PEG and angiopep-2 constituted an ideal dual targeting drug delivery system for both BBB and glioma cells [26].\nFor some inorganic nanoparticles, lactoferrin (Lf) conjugation showed better efficiency in BBB penetration than PEG modification as a result of Lf-receptor-mediated transcytosis of cerebral endothelial cells. It has been found that the PEG coating favors the transfer of the underlying Fe3O4 nanoparticles across the intact\nBBB model, while Lf-conjugated Fe3O4 nanoparticles exhibited an enhanced ability to cross the BBB in comparison with the PEGcoated Fe3O4 nanoparticles [27]. Free cationic serum albumin can enter the brain via an adsorptive-transcytosis mechanism; and likewise, it has shown that magnetic nanoparticles of MnFe2O4 surfacely coated with crosslinked serum albumin demonstrated the capability of BBB permeability without any breakdown [28]. Other surface coatings, such as poly(isobutylene-alt-1-tetradecene-maleic anhydride) (PMA), also facilitate BBB penetration of iron oxide nanoparticles uploaded with therapeutic molecules [29].\nIn addition to chemical modification, physical approaches such as magnetism can also be used for the enhancement of BBB penetration of Fe3O4 nanoparticles because of their capacity to be magnetized in the presence of a magnetic field. It has been found that superparamagnetic iron oxide nanoparticles (SPIONs) composed of magnetite (Fe3O4) and maghemite (c-Fe2O3) can pass through human brain microvascular endothelial cells facilitated by an external magnet, which showed the magnetic force-mediated dragging of SPIONs through the BBB may denote a novel mechanism for the delivery of drugs to the brain [30].\nOther inorganic nanoparticles, such as gold nanoparticles (GNPs), have also been investigated for drug transport across the intact BBB [31]. Although all research results showed inorganic nanoparticles are promising carrier vehicles to deliver drugs into brain, the issues of potential toxicity as a result of nondegradability and drug delivery efficiency still need to be addressed [32]."
    }, {
      "heading" : "Solid lipid nanoparticles",
      "text" : "Solid lipid nanoparticles (SLNs) are nano-sized dispersions of biocompatible lipids, such as triglycerides, fatty acids or waxes, stabilized by surfactants possessing HLB (hydrophile–lipophile balance) values lower than 12 [33,34]. With drugs that can be dissolved or dispersed in the hydrophobic core, such nano carriers possess the capability to deliver drugs into cells. A drug-loaded SLNs suspension consisted of 0.1% (w/w) camptothecin (the model drug), 2.0% (w/w) stearic acid, 1.5% (w/w) soybean lecithin and 0.5% (w/w) polyoxyethylene–polyoxypropylene copolymer (Poloxamer 188) with the average diameter of 196.8 nm and the zeta potential of 269.3 mV exhibited higher drug concentration in the brain, heart and reticuloendothelial cells containing organs after intravenous injection in comparison to free camptothecin, which indicated that it was possible for the SLNs to cross the BBB [35]. SLNs made from stearic acid stabilized with pluronicVR F68 showed the possibility to effectively deliver atazanavir to human brain endothelial cells in vitro [36]. In vivo test in rats also showed that riluzole-uploaded SLNs exhibited a higher capability to carry the drug into the brain [37].\nSurface modification of SLNs with targeting ligands could be an effective strategy for BBB delivery. Docetaxel-loaded SLNs have been prepared from monostearin, vitamin E and soya lecithin, followed by surface modification with stearylamine–betreliesoxybutyric acid (HBA, a ketone body and substrate for monocarboxylic acid transporter which is expressed on BBB) conjugate, for drug transport across the intact BBB [38]. The surface modification of docetaxelloaded SLNs with HBA resulted in enhanced brain uptake of docetaxel compared with un-modified docetaxel-loaded SLNs and TaxotereVR , which showed HBA present on the surface of SLNs caused the nanoparticles to be taken up by the monocarboxylic acid transporter as normal HBA and improved the brain uptake of docetaxel compared with un-modified SLNs. Similarly, Transferrin (Tf)-conjugated, quinine dihydrochloride-uploaded SLNs made from hydrogenated soya phosphatidyl choline (HSPC), triolein, distearylphosphatidylethanolamine (DSPE) and cholesterol revealed enhanced uptake in brain tissue compared with un-conjugated\nSLNs [39]; it has also been demonstrated that poly(ethylene glycol)grafted SLNs made from stearate using egg phosphatidyl choline and sodium glycocholate as surfactants uploaded with noscapine can improve drug accumulation in mice brain tissue [40].\nActing as a carrier vehicle for drug delivery, SLNs have shown the advantages of good biocompatibility, degradability as well as the capacity to be surfacely functionalized for brain targeting, while the issue of easy clearance by the RES as a result of their hydrophobicity needs to be addressed."
    }, {
      "heading" : "Polymeric nanoparticles",
      "text" : "Polymeric nanoparticles are solid carrier vehicles ranging from 1 to 1000 nm in diameter made from natural or synthetic polymers. According to the drug-loading methods, therapeutic moleculesuploaded polymeric nanoparticles can form nanospheres (drugs are uploaded throughout or just onto the surface of the polymeric matrix) or nanocapsules (drugs are surrounded by a polymeric shell) that are thermodynamically stable [41]. As a result of the diversity of polymers, polymeric nanoparticles can be designed to achieve desired properties, such as controlled and/or sustained drug release profile, as well as allowing drug release at the targeted site over a period of time [42]. For this reason, a variety of polymers have been investigated to form nanoparticles for brain drug delivery. b-Cyclodextrin, which is composed of cyclic oligosaccharides with seven glucose unites that form a hydrophobic central cavity with the capacity to host therapeutic molecules, has been quarternized for the preparation of a series of quaternary ammonium b-cyclodextrin (QA-CD) nanoparticles. Uploaded with DOX, QA-CD nanoparticles showed permeability across the in vitro BBB by means of endocytosis [43]. DOX-uploaded nanoparticles of bcyclodextrin crosslinked with b-amino ester also showed biocompatibility and permeability in an in vitro BBB model without impairing the integrity of the barrier [44]. Another synthetic polymer, namely poly(MePEG2000cyanoacrylate-co-hexadecylcyanoacrylate) (PEG-PHDCA), demonstrated the capacity of their nanoparticles to reach the rat central nervous system (CNS) after intravenous injection [45]. In contrast, polyhexadecylcyanoacrylate (PHDCA) nanoparticles did not penetrate across the BBB as a result of less adsorbed apolipoprotein E (ApoE) as well as apolipoprotein B-100 (ApoB-100) than PEG-PHDCA nanoparticles, which demonstrated that the involvement of apolipoproteins played an important role in the brain transport of PEG-PHDCA nanoparticles [46].\nIt has been found that some surfactants can enhance the permeability of polymeric nanoparticles across the BBB; poly(butylcyanoacrylate) (PBCA) nanoparticles coated with polysorbate 80 have been successfully used to transport drugs, such as leu-enkephalin dalargin, met-enkephalin kyotorphin, rivastigmine and tacrine, through the BBB after intravenous injection [47–51]. PBCA is a biodegradable and biocompatible polymer; PBCA nanoparticles showed hardly any cytotoxic or inflammatory effect at therapeutic concentrations and incubation times, and they did not induce nonspecific BBB disruption, but collaborate with plasma apolipoprotein E to facilitate BBB crossing [52,53].\nPoly(lactic-co-glycolic acid) (PLGA) is a polymer with biodegradable and biocompatible nature which has been approved by the US FDA for human use. Research has shown that PLGA nanoparticle-delivered dopamine reduced its autoxidation-mediated toxicity in the brain and reversed neurochemical and neurobehavioral deficits in parkinsonian rats [54]. When uploaded with a protein drug (tissue inhibitor of matrix metalloproteinases 1, TIMP-1), PLGA nanoparticles coated with polysorbate 80 had 11.21 ± 1.35% penetration, whereas TIMP-1 alone and PLGA nanoparticles without polysorbate 80 coating did not cross the endothelial monolayer.\nDue to no significant opening of the BBB caused by uncoated as well as polysorbate 80 coated PLGA nanoparticles, polysorbate 80 coating can be used to enhance protein delivery of PLGA nanoparticles across the BBB [55].\nIn addition to coating with surfactants, surface functionalization with certain peptides can also facilitate BBB penetration of polymeric nanoparticles. Surface-modified PLGA nanoparticles with octa-arginine (R8) showed a faster cell uptake compared with the control [56], while the fluorescent aminated polystyrene (PS) nanoparticles surfacely functionalized with gH625 (a viral fusion peptide derived from the glycoprotein gH of herpes simplex virus type I) via a covalent-binding procedure showed a greater uptake by brain endothelial cells than that of the PS nanoparticles without the peptide [57]. Modification with a motif of TGNYKALHPHNG (TGN) could facilitate BBB penetration of poly(ethylene glycol)poly(D,L-lactide-co-glycolide) (PEG-PLGA) nanoparticles, leading to significant higher cellular uptake and in vivo brain accumulation [58].\nAs a result of receptor-mediated endocytosis being one of the mechanisms through which nano carriers cross the BBB, surface functionalization with targeting ligands represents another approach to facilitate BBB penetration of polymeric nanoparticles. Angiopep, a ligand targeting the low-density lipoprotein receptorrelated protein (LRP) which is overexpressed on the BBB and glioma cells, has been conjugated with poly(ethylene glycol)-poly(ecaprolactone) (PEG-PCL) nanoparticles [59]. Compared with nontargeting nanoparticles, a significantly higher amount of rhodamine isothiocyanate-labeled targeting nanoparticles were endocytosed by U87 MG cells. Tf conjugated nanoparticles of poly(lactide)-D-a-tocopheryl polyethylene glycol succinate (PLA-TPGS) diblock copolymer showed more efficiency than the bare PLATPGS nanoparticles in brain delivery [60], while human serum albumin (HSA) nanoparticles covalently coupled with Tf or transferrin receptor monoclonal antibodies (OX26 or R17217) also demonstrated the capacity to transport drugs across the intact BBB [61]. Lf, a mammalian cationic iron-binding glycoprotein belonging to the transferring family, consists of a polypeptide chain of about 690 amino acids folded into two globular lobes, when conjugated with poly(ethylene glycol)-poly(lactide) nanoparticles, significantly facilitates cell uptake of the nanoparticles [62]. After intravenous administration, near three folds of coumarin-6 were found in the mice brain carried by Lf-conjugated nanoparticles compared to that carried by the bare nanoparticles.\nCampared with synthetic polymers, nanoparticles based on natural polymers showed advantages of low cost, less toxicity and biodegradability, which provide a potential candidate for brain drug delivery. A pluronic-based nano carrier conjugated with both chitosan and a specific target peptide for brain (rabies virus glycoprotein; RVG29) was effective for brain targeting across the intact BBB [63]. Chitosan nanospheres conjugated with an anti-mouse transferrin receptor monoclonal antibody (TfRMAb) that selectively recognizes the TfR type 1 on the cerebral vasculature clearly demonstrated the effectiveness of bringing active peptides to the brain [64]. Chitosan nanospheres conjugated with poly(ethylene glycol) (PEG) bearing the OX26 monoclonal antibody whose affinity for the transferrin receptor (TfR) may trigger receptor-mediated transport across the BBB successfully translocated into the brain tissue after intravenous administration [65].\nDue to hydrophobic molecules exhibiting better permeability in BBB penetration than hydrophilic ones, chitosan has been chemically modified to improve hydrophobicity for permeability improvement of the nanoparticles in BBB penetration. Trimethylated chitosan (TMC) has been synthesized and covalently coupled to the surface of PLGA nanoparticles (PLGA-NP) via a\ncarbodiimide-mediated link, the resulted nanoparticles exhibited negligible cytotoxicity and enhanced brain uptake following intravenous administration compared with PLGA nanoparticles without TMC conjugation [66]. A series of O-substituted alkylglyceryl chitosans with systematically varied alkyl chain length and degree of grafting has been prepared through synthetic steps that involved the protection of amino moieties via phthaloylation and employed for the formulation of aqueous nanoparticulate systems. During in vitro tests using a mouse-brain endothelial cell model, the efficient cellular uptake of these nanoparticles has demonstrated and identified butylglyceryl chitosan and butylglyceryl N,N,N-trimethyl chitosan as promising materials for the formulation of nanoparticles that could act as drug carriers into the brain [67].\nWith the possibility of achieving designed and tailored properties, polymeric nanoparticles have significant potential for brain drug delivery across the BBB. Biodegradable polymers exhibit the advantage of less accumulation in the body; however, before translation into clinical use, a good knowledge of degradation rates as well as catabolites, toxicity, and the possibility of causing adverse immunological responses is necessary."
    }, {
      "heading" : "Nanogels",
      "text" : "Gels are physically or chemically crosslinked three-dimensional (3D) polymeric networks that swell in certain liquids with compatible interfacial energies, and the swollen networks can retain a large amount of absorbed liquids [68]. Both aqueous and organic liquids can be supporting media of polymeric gels, leading to the formation of hydrogels and organic gels, respectively [69]. With good biocompatibility as a result of their relatively high water content, as well as the possibility of pharmaceutical molecules to diffuse into (drug loading) and out of (drug release), the swollen polymeric networks, hydrogels have been widely investigated for drug delivery [70,71].\nNanogels are nanoparticles of hydrogels and offer the prospect of drug transport across the intact BBB. It has been reported that nanogels with surface charge exhibited better internalization property on cell membrane than neutral ones; Gil and Lowe synthesized polysaccharide-based nanogels containing poly(b-amino ester) and b-cyclodextrin for transporting doxorubicin and insulin across the BBB, such cationic nanogels enhanced the permeability of insulin across the in vitro BBB model by 20% [72].\nIt is known that lipophilic molecules are easier to penetrate the BBB than hydrophilic ones; so surface functionalization of nanogels has been introduced to accelerate encapsulated drug transport across the BBB. Azadia et al. prepared nanogels loaded with methotrexate (MTX) via an ionic gelation process using chitosan and sodium tripolyphosphate (TPP) as raw materials, the surfaces of the MTX-loaded nanogels were modified with polysorbate 80 to improve brain drug delivery [73]. The cumulative in vitro release profiles indicated non-Fickian diffusion kinetic, apparently governed by both diffusion of the drug out of the nanogels and swelling/disintegration of the polymeric networks for both surfactant coated and uncoated nanogels. After intravenous administration, remarkably higher brain concentrations of methotrexate were achieved with the nanogel formulations in comparison to the free drug, but there were no significant differences between the surface-coated and uncoated nanogels [74].\nTwo proteins, connexin 43 (Cx43) and brain-specific anion transporter 1 (BSAT1), which are promising targeted antigens for drug delivery to gliomas, have been respectively conjugated with the cisplatin-loaded nanogels prepared from aqueous solutions of poly(ethylene glycol) (PEG)-block-poly(methyl methylacrylate) (PMAA) and CaCl2 using 1,2-ethylenediamine and\n1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride (EDC) as crosslinkers, for the treatment of intracranial gliomas [75]. The median survival of rats treated with targeted nanogels conjugated with specific mAbs against extracellular loops of Cx43 and BSAT1 were 27 and 26.6 days longer than that in control group, respectively, which suggested the effectiveness of the ligands in promoting BBB-penetrating efficiency of the nanogels. Conjugation of insulin and Tf with the nanogels of crosslinked poly(ethylene glycol) and poly(ethylenimine) for the delivery of oligonucleotide in brain also showed similar results [76]. Being hydrophilic carriers, nanogels are favorable in uploading aqueously soluble drugs as well as proteins and nuclear acids, while it is unsuitable for hydrophobic drugs."
    }, {
      "heading" : "Micelles",
      "text" : "Micelles are made from amphiphilic block copolymers that aggregate in aqueous solutions to form stable spheroidal nano structures with a hydrophobic core and hydrophilic surface [77]. As a result of the possibility of solubilizing poorly water-soluble, lipophilic compounds in the hydrophobic core region through hydrophobic interaction and/or hydrogen bonding for easy administration, as well as the capacity to conjugate with certain targeting ligands, micelles are promising delivery vehicles for brain drugs.\nA polymeric surfactant, poly(oxyethylene)-poly(oxypropylene) block copolymer (pluronic), has been used for the preparation of micelles [78]. Fluorescein isotbiocyanate (FITC) was solubilized in the micelles; it has been found that conjugation of FITC-containing micelles with insulin vector resulted in increase of FITC penetration in all tissues including the brain. By conjugating the micelles with antibodies to the antigen of brain glial cells (a2-glycoprotein), the specific targeting of the solubilized FITC was observed in the brain, which showed that vector-containing pluronic micelles provide an effective transport of solubilized neuroleptics across the BBB.\nTAT (49–57, YGRKKRRQRRR) peptide, the protein transduction domain from the transcriptional activator TAT protein of the human immunodeficiency virus type 1, has been anchored with cholesterol-terminated poly(ethylene glycol) (PEG) with a molecular weight of about 3 kDa (PEG-b-Chol), to form a functionalized TATPEG-b-Chol amphiphilic block copolymer [79]. FITC-loaded polymeric micelles self-assembled from the block copolymer exhibited the possibility of crossing the BBB and entering the brain, which showed that the TAT-conjugated micelles may in the future be used to deliver antibiotics across the BBB for the treatment of brain infections.\nSeveral amphiphilic block copolymers have been synthesized and used for the preparation of micelles; and several targeting ligands have been conjugated for the improved crossing of the intact BBB, such as poly(ethylene glycol)-block-poly-(L-glutamic acid), poly(ethylene glycol)-block-poly(D,L-lactide acid), cholesterol conjugated polyoxyethylene sorbitol oleate (CPSO), cyclic Arg-GlyAsp (cRGD) ligand and angiopep (a family of 19 amino acid peptides derived from the Kunitz domain) [80–82]. However, the efficiency of micelles delivering drugs across the intact BBB still needs further investigation."
    }, {
      "heading" : "Liposomes",
      "text" : "Liposomes are nano-sized vesicles with an aqueous inner core enclosed by unilamellar or multilamellar phospholipid bilayers. The common constituents that form part of phospholipid bilayer are naturally produced sphingomyelin, phosphatidylcholine or glycerophospholipids [83]. With good biocompatibility, as well as the\npossibility of uploading drugs in the aqueous core, liposomes have been widely investigated for systemic delivery of therapeutics [84].\nSeveral issues have impeded the drug delivery application of conventional liposomes; one is opsonization and rapid clearance by macrophages of the mononuclear phagocytic system (MPS) organs. By using surface coatings, such as poly(ethylene glycol) (PEGylated liposomes), the circulation time of liposomes in the body can be prolonged [85]. Another is their low drug transport rate. By conjugating with targeting ligands, liposomes showed the possibility to transport drugs to certain organs including the brain. For example, the lipid bilayer of a 3/7 cholesterol/dipalmitoylphosphatidylcholine mixture was coated with n-alkyldimethylammoniumcyclodextrins which host adamantoylglucose molecules as a result of the adamantoyl moieties being included in the cyclodextrin cavities; such liposomes showed a 5-fold improved ability to enter the BBB endothelial cells compared with the non-coated samples [86]. The glucose moiety of the ligand provided special affinity of the liposome with BBB endothelial cells, leading to an improvement of the transport rate. Doxorubincin liposomes conjugated with both folate and transferrin (Tf) also showed effectiveness in penetrating the BBB and targeting brain tumors [87].\nCationization of the conjugated ligands is another method to improve BBB transport rate of liposomes. Liposomes made from cholest-5-en-3-ol-(3b)-[2-[[4-[(carboxymethyl) dithio]-1-iminobutyl]amino]ethyl] carbamate (CHETA5), a cholesterol derivative with a disulfide bond inside, were neutral or negatively charged at physiological pH. When they touched brain capillary endothelial cells with the help of a brain-targeting ligand, Lf, they were changed into cationic liposomes [88]. Such liposomes showed an improved performance in the uptake efficiency and cytotoxicity of the primary brain capillary endothelial cells. Liposomes conjugated with cationized bovine serum albumin showed similar results compared with sterically stabilized (PEGylated) liposomes without protein as well as liposomes conjugated with native bovine serum albumin [89].\nOther issues limiting the brain delivery of liposomes are the poor stability, as well as the difficulty of binding ligands to the surface as a result of the small number of available surface groups and steric hindrance."
    }, {
      "heading" : "Dendrimers",
      "text" : "Dendrimers are monodisperse symmetric macromolecules that comprise a series of branching units around an inner core [90]. With many reactive groups on the surface, the number of arms and surface groups exponentially increase with each generation [91].\nBeing composed of repetitive units of branched molecules, dendrimers form a 3D spheroidal shape and radially crowded layers. As a result, the core is loosely packed in comparison to the periphery and is suitable for the entrapment of drugs. In addition, the presence of numerous surface groups allows for high drug payload and/ or multifunctionality. Combined with their nanometer size range, dendrimers are attractive carrier vehicles for drug delivery [92].\nThe surface groups of dendrimers can be conjugated with ligands for transport across the BBB, as well as for targeting specific cells such as tumor cells. Thus, dendrimers are promising tailorable delivery systems for improved delivery of drugs to the brain. Li et al have synthesized the fourth-generation poly(amidoamine) (PAMAM) dendrimers with transferrin (Tf) conjugated on the exterior and tamoxifen (TAM) encapsulated in the interior [93]. It has been found that each dendrimer is a pH-sensitive drug carrier that can encapsulate 29 TAM molecules in the interior and bond 7 doxorubicine (DOX) molecules, over 30 PEG1000 and PEG2000 chains and one Tf group on the periphery.\nThe drug–dendrimer conjugate showed a fast drug release profile at weak acidic condition and a stable state at physiological environment, as well as a good BBB transportation ability with the transporting ratio of 6.06% in 3 h. Angiopep, a ligand targeting to the low-density lipoprotein receptor-related protein-1 (LRP1), has been conjugated with PAMAM dendrimers for effective brain-targeting gene delivery [94]. Such a nano carrier was observed to be internalized by brain capillary endothelial cells (BCECs) through a clathrin- and caveolae-mediated energy-depending endocytosis, also partly through marcopinocytosis. Compared with the dendrimers without modification, angiopep-modified dendrimers showed higher efficiency in crossing the intact BBB and more in vivo accumulation in the brain. Other research results also showed the capacity of targeting ligand conjugated dendrimers to cross the intact BBB [95,96].\nBefore translation of dendrimers into brain drug delivery use, it is necessary to address their biocompatibility issue. For example, PAMAM dendrimers have been shown to be hemolytic and cytotoxic [97]. Some research results also showed that biotinylated PAMAM dendrimers may prove to be more toxic compared to PAMAM dendrimers alone [98]."
    }, {
      "heading" : "Nanoemulsions",
      "text" : "Nanoemulsions are heterogenous dispersions of oil-in-water (O/W) or water-in-oil (W/O) formulations stabilized with surface-active agents, where diameter of the inner phase is reduced to nanometer length scale [99]. The possibility of surface functionalization for targeting, as well as the ability to solubilize hydrophobic (O/W nanoemulsions) or hydrophilic (W/O nanoemulsions) drugs, could facilitate the uptake of nanoemulsions along with its encapsulated drugs through receptor-mediated endocytosis of cells, which makes nanoemulsions are promising carrier vehicles for drug transport across the BBB.\nFor biocompatibility purpose, nanoemulsions are usually made from edible oils, such as flaxseed oil, pine-nut oil, hemp oil, fish oil as well as safflower oil and wheat-germ oil, biocompatible surfactants such as egg phosphatidylcholine which is one of the components of cell membrane lipids, deoxycholic acid, stearylamine, dioleoyltrimethylammoniumpropane (DOTAP) and water. The versatility of nanoemulsions is based on the different types of oils and surface modifiers that can be used [100]. The nanoemulsions of pine-nut oil with the oil droplet size of approximately 200 nm in diameter have been formulated for the delivery of paclitaxel (PTX) and C6-ceramide (CER) to the brain [101]; it has been found that the O/W nanoemulsions can improve the cytotoxic effect in brain tumor cells. As a result, pine-nut oil with high gamma linolenic acid content was expected to rapidly penetrate across the BBB and thus, incorporating paclitaxel in pine-nut oil-containing nanoemulsions was hypothesized to increase the drug availability in the brain.\nIn another study, O/W nanoemulsions containing saquinavir (SQV), an anti-HIV protease inhibitor, have been developed by dissolving SQV in different types of edible oils rich in essential polyunsaturated fatty acids (PUFA), followed by emulsifying in water-containing surfactants LipoidVR -80 and deoxycholic acid [102]. When administered orally and intravenously to male Balb/c mice, the resultant flax-seed oil nanoemulsions with an average oil droplet size of 100–200 nm showed enhanced rate and extent of SQV absorption in the brain in contrast to aqueous suspension formulation.\nCompared with other nano carriers, the advantages of nanoemulsions for overcoming the BBB are the ability to utilize safe oils, as well as possessing several beneficial biological properties as a result of essential omega-3 and omega-6 fatty acid in the oils.\nHowever, the thermodynamic instability is a shortcoming of nanoemulsions and requires further considersation."
    }, {
      "heading" : "Exosomes",
      "text" : "Exosomes are a kind of nano-sized membranous vesicle secreted by a number of cell types and can be isolated from conditioned cell media or bodily fluids such as urine and plasma [103]. Once released from a cell, exosomes can fuze with membrane of another cell, transferring exosomal molecules from one cell to another [104]. This property provides exosomes with the chance to transport drugs into cells. The uptake mechanism of exosomes is clathrin-mediated endocytosis followed by back fusion with the limiting membrane of the endosomes, allowing for the possibility of exosomes to cross the intact BBB [105].\nBeing secreted by living cells in the body, exosomes are natural delivery vehicles with advantages of non-toxicity, minimal immune responses, and better stability in the circulatory system in contrast to established formulations [106]. Alvarez-Erviti et al. used selfderived dendritic cells for exosome production; targeting peptides for muscle and brain were used to functionalize the exosomes [107]. Uploading exogenous siRNA onto the exosomes by electroporation, it has been found that the exosomes delivered siRNA specifically to neurons, microglia and oligodendrocytes in the brain, resulting in a specific gene knockdown after intravenous injection. Yang et al. isolated four types of exosomes from brain cell culture media for drug delivery, and found that exosome-delivered anticancer drugs crossed the intact BBB and entered into the brain [108].\nProof of concept has been gained for exosome-based brain drug delivery systems; several issues should be addressed before clinical evaluation such as the choice of exosome donor cells, drug loading procedures, as well as the targeting peptides."
    }, {
      "heading" : "Quantum dots",
      "text" : "Quantum dots are a class of colloidal semiconductor nano crystals composed of a metalloid crystalline core (such as cadmium selenium) and an intermediate unreactive metallic shell (such as zinc sulfide) that shields the core [109]. Such an inorganic nano material has high brightness, long-term photostability and size-tunable narrow emission spectra, which makes it a revolutionary imaging technology for diagnostic purposes (fluorescent probes) [110]. With the possibility of being co-incorporated with a variety of diagnostic and therapeutic molecules for targeted therapy of CNS disorders as a result of their high surface area, quantum dots also showed the potential as a carrier vehicle for blood-to-brain drug delivery.\nThe outer coating of quantum dots can be chemically functionalized with bioactive molecules that promote aqueous solubility and desired bioactivity, enable targeting of specific molecules, as well as carrying therapeutic molecules [111]. Captopril-conjugated CdSe/ZnS-core/shell-typed quantum dots (QDs-cap) have been synthesized by the hot soap method with tri-n-octyl phosphine oxide (TOPO) followed by the replacement of TOPO with captopril by a thiolexchange reaction. It has been found that intraperitoneally administered QDs-cap in mice were delivered through systemic blood circulation into the brain as well as into the liver, spleen and kidney, which showed the possibility of such quantum dots to penetrate the BBB [112].\nIt is widely known that the Tf receptor is a kind of specific BBB transporter that allows selected biomolecules to move across the BBB; lysine-coated CdSe/CdS/ZnS quantum dots have been synthesized followed by conjugation with Tf. It has been found that the migration rate of such Tf-conjugated QDs crossing the in vitro BBB\nmodel was concentration- and time-dependent after a systemic administration, which demonstrated a receptor-mediated transport mechanism [113].\nTAT, a cell membrane translocation peptide, has been successfully used to internalize nanoparticles [114]. Research has shown that TAT-conjugated CdS:Mn/ZnS quantum dots can label the brain tissue within a few minutes after being intra-arterially delivered to a rat brain without manipulating the BBB; such TAT-conjugated quantum dots migrated beyond the endothelial cell line and reached the brain parenchyma [115,116]. Because the same quantum dots without TAT did not label the brain tissue, TAT peptide was necessary for the quantum dots to overcome the BBB."
    }, {
      "heading" : "Polymersomes",
      "text" : "Polymersomes are a nanometer-sized vesicular system with a bilayered membrane which is composed of amphiphilic block copolymers [117]. Such tiny hollow spheres can be formed from synthetic amphiphilic block copolymers using organic solvent, organic solvent/water systems or aqueous media. Usually, amphiphilic block copolymers with a hydrophilic fraction of 35 ± 10% will aggregate to form polymersomes [13,118].\nPolymersomes enclose an aqueous solution in the core, which is useful for encapsulation and delivery of hydrophilic drugs, while the membrane of copolymer aggregates bi-layer can be loaded with small hydrophobic drugs [119,120]. Polymersomes are similar to liposome in structure; the main difference is that the external bi-layer is composed of amphiphilic copolymers with a molecular weight of up to 100 kDa, while the building block of liposome is in most cases naturally occurring phospholipid with a molecular weight below 1 kDa [121,122]. With regard to the use of building blocks with high molecular weight, the membrane of polymersomes is thicker than that of liposome, providing a higher durable physical barrier that protects the enclosed drugs [123]. When used for drug delivery, the more robust and therefore less leaky membrane of polymersome can improve circulation time and prevent uncontrolled release of drugs [124,125].\nBeing a nano carrier vehicle, polymersomes have been functionalized with certain receptors for brain drug delivery across the BBB. Pang et al synthesized biodegradable poly(ethyleneglycol)-poly(ecaprolactone) (PEG-PCL) and used the block copolymer to prepare polymersomes (PO) by a nano precipitation method [126]. To facilitate brain targeting, the polymersomes were functionalized with Tf to form a conjugate Tf-PO. Using coumarin-6 as a model drug, fluorescent microscopy of brain coronal sections revealed more TfPO than PO accumulated in the brain after injection, and it has been evidenced that Tf-PO uptake by beta-End.3 cells occurred mainly through a clathrin-mediated, energy-dependent endocytosis and that both the golgi apparatus and lysosomes were involved in intracellular transport of Tf-PO.\nLf also belongs to the transferring family and exists on the BBB involved in Lf transport across the BBB, which provides another chance for brain targeting of polymersomes. Gao and coworkers prepared polymersomes of poly(butadiene-b-ethylene oxide) (PBD-PEO), poly(ethylene glycol-b-lactic acid) (PEG-PLA) and maleimide-PEG-PLA (Mal-PEG-PLA) (the weight ratio of PBD-PEO:PEGPLA:MAL-PEG-PLA was 7:2:1) using the film rehydration method [127], both Lf and Tf were used to functionalized the polymersomes (Lf-PO and Tf-PO) for brain targeting. It was found that cell uptake of both Lf-PO and Tf-PO were time-, temperature- and concentration-dependent, which suggested a process of active endocytosis. Tf was more effective than Lf in facilitating cell uptake of the nano carriers, and Lf-PO was more easily identified and\neliminated by cells of the mononuclear phagocytic system (MPS). Polymersomes prepared by self-assembly of methoxy-PEG-PLGA and maleimide-PEG-PLGA which were synthesized by the ring opening polymerization of D,L-lactide and glycolide showed similar results when conjugated with Tf [128].\nSeveral polymersomes have been investigated for brain drug delivery; various receptors expressed on the BBB such as low-density lipoprotein receptor, insulin receptor, insulin-like growth factor receptor, diphtheria toxin receptor and nicotinic acetylcholine receptor provided many chances for the functionalization of polymersomes to mediate their penetration of the BBB. Poly(carboxyl ethylene glycol-g-glutamate)-co-poly(distearin-g-glutamate) (CPEG GM-PDSGM) copolymer, poly(methyl ethylene glycol-g-glutamate)copoly(distearin-g-glutamate) (mPEGGM-PDSGM) copolymer, desoctanoyl ghrelin-poly(ethylene glycol-gglutamate)-co-poly(distearing-glutamate) (des-octanoyl ghrelin-PEGGM-PDSGM) copolymer, poly(tert-butyl hydrazinecarboxylate ethylene glycol-g-glutamate)-copoly(distearin-g-glutamate) (BPEGGM-PDSGM) copolymer, as well as folate-poly(ethylene glycol-g-glutamate)-co-poly(distearin-g-glutamate) (folate-PEGGM-PDSGM) copolymer have been prepared, different types of polymersomes based on such copolymers have been developed and conjugated with both des-octanoyl ghrelin and folate as a penetrating-targeting carrier for an enhanced drug transport through the BBB and glioma cells targeting [129]. It has been found that with bi-functional ligands on the surface of polymersomes, the BBB transport was greatly enhanced and the inhibition of glioma growth was significantly improved via a synergistic effect of two different endocytosis mechanisms by des-octanoyl ghrelin and folate.\nAlthough several research results showed the possibility of receptor functionalization-mediated BBB penetration of polymersomes, the efficiency of drug transport was not ideal. In addition, the application of protein and antibody receptors is restricted by their instability and immunogenicity.\nMechanisms of nanomaterials transporting drugs across the BBB\nBased on the biological characteristics of the BBB, the mechanisms of nano carriers transporting drugs across the BBB can be classified as follows: (1) transient BBB opening induced by the stimulus derived from ‘‘nano effects’’ or ‘‘nano toxicity’’ of the nano carriers, or the stimulus of surfactants coated on the surface of nano carriers, which results in diffusion of the drugs or drug–carrier conjugates into the brain parenchyma; (2) adsorption of the drug–carrier conjugates onto the surface of brain capillary endothelial cells, followed by drug release from the carrier vehicles on the surface, which increases drug concentration gradient facilitating diffusion of the drugs into the brain parenchyma; (3) transcytosis, endocytosis and exocytosis of the drug-carrier conjugates by brain capillary endothelial cells, which results in direct penetration into the brain parenchyma or the cells [130–132].\nIt has been found that some chitosan-derived nanoparticles were capable of opening the tight junctions of the BBB [133,134], while high concentrations of some anionic nanoparticles and cationic nanoparticles disrupted the BBB even though neutral nanoparticles and low concentrations of anionic nanoparticles have no effect on BBB integrity [135]. Sodium dodecylsulphate, a surfactant which is regarded as biocompatible, has also been found the capability to induce a breach in the blood–brain barrier [136]. Transient BBB opening as a result of the stimulus derived from nano carriers or surfactants is dangerous as a result of the nano carrier’s toxicity, as\nwell as the possibility of other molecules in blood stream diffusing into the brain parenchyma at the same time.\nAdsorption of the drug–carrier conjugates onto the surface of brain capillary endothelial cells depends on hydrophilicity, surface charge, and targeting ligands of the nano carrier. A lipophilic surface of the nano carrier facilitates the adsorption; and a positive surface charge of the nano carrier promotes electrostatic interactions with the negative charges of endothelial surfaces which also facilitate the adsorption [137,138]. Targeting ligands, such as the apolipoproteins, in plasma adsorbed on the surface of the nano carrier can target low-density lipoprotein receptors on the microvessel endothelial cells, which facilitates the adsorption [139].\nFor the fate of drug–carrier conjugates adsorbed on the surface of brain capillary endothelial cells, one is desorption followed by reentering the blood stream. In this case, the uploaded drug can release from the carrier vehicle on the surface of BBB during adsorption and then diffuse into the brain parenchyma through the BBB. Therefore, the possibility of drug penetrating into the brain parenchyma will be determined by characteristics of the drug. To promote drug transport across the BBB, it is necessary to modify the surface of the nano carriers for the minimization of clearance by the fixed macrophages of the mononuclear phagocytic system (MPS) and prolonged blood circulation enhancing exposure of the BBB. Improving hydrophilicity and increasing surface charge are good methods for nano carriers to mask themselves from the MPS. Another fate of the adsorbed drug–carrier conjugates is endocytosis by the cells, sometimes followed by exocytosis, leading to penetration of the nano carrier into the cells or brain parenchyma.\nEndocytosis may occur by means of random uptake of soluble plasma molecules together with a bulk of plasma by caveolaes on the cells; such a process is independent of any interaction between the transported molecules and the caveolar vesicle membrane [140]. Because the brain capillary endothelial cells are characterized by few caveolaes, while a high density of negatively charged and clathrin-coated pits through which drug–carrier conjugates can be be endocytosed, endocytosis of drug-carrier conjugates is mainly based on the adsorption of drug–carrier conjugates to the clathrincoated pit membrane [141].\nAlthough it is a normal biological function of cells, endocytosis is energy dependant, which does not exhibit any preference for nano carriers conjugated with drugs, leading to a low efficiency of drug transport across the BBB. Several approaches have been proposed to promote endocytosis of nano carriers by brain capillary endothelial cells; one is coating the nano carriers with surfactants whose effectiveness has been testified. Three mechanisms have been proposed to explain surfactant-coating promoted endocytosis, namely [142–146]: (1) polysorbate 80 or poloxamers 188- induced adsorption of apolipoproteins A-I and/or E in plasma onto the surface of the nano carrier facilitating targeting low density lipoprotein receptors on the cell membrane; (2) surfactant-induced fluidity of the cell membrane contacted with the adsorbed drugcarrier conjugates facilitating deformation of the cell membrane and promoting endocytosis; and (3) surfactant-induced BBB opening.\nPromoting adsorption of drug–carrier conjugates to the brain capillary endothelial cells is another approach to prompt endocytosis; seeking help from specific carriers, transport proteins or receptors on the membrane of cells has been employed. The relative high BBB permeability of acrylic nanoparticles has been attributed to the apolipoproteins in plasma adsorbed on the surface of the nano carrier targeting low-density lipoprotein receptors on the microvessel endothelial cells by some researchers [147]. Many nano carriers have been surfacely functionalized with a series of\nfunctional peptides such as Tf and Lf, and both in vitro and in vivo tests have shown their effectiveness in promoting BBB penetration of the nano carriers. Because such specific carriers, transport proteins or receptors expressed on the membrane of brain capillary endothelial cells are limited, the possibility of achieving a minimal effective drug concentration in the brain parenchyma by carrier-, transporter-, and receptor-mediated endocytosis of nano carriers is worthy of suspicion. For example, from the data available, the percentages of injected drug dose found in the brain after targeting with nano carriers was less than 1% [148]."
    }, {
      "heading" : "Perspective",
      "text" : "Brain drug delivery via the circulatory system is limited by the BBB, which hinders therapy, diagnosis and prevention of cerebral diseases. Being a noninvasive approach, nanomaterials-mediated delivery transporting drugs across the intact BBB has shown the advantages of safety, low cost, as well as suitability for almost all drugs in contrast to other approaches of brain drug delivery. A variety of nanomaterials have been investigated for drug transport across the BBB; both in vitro and in vivo tests have testified the effectiveness of nanomaterials-mediated brain drug delivery. However, despite considerable advances that have resulted in improved brain drug delivery profiles over other brain delivery approaches, several issues have impeded the therapeutic application of nano carriers in brain drug delivery, namely: rapid opsonization, the fast and non-specifc clearance from the circulatory system by reticulo-endothelial system (RES) cells of nano carriers with hydrophobic/neutral surfaces; the metastable nature of some nano carriers; limited drug loading capacity; need to co-formulate with surfactants and cosolvents; aggregation or cluster formation in blood flow of neutral or hydrophobic nano carriers; and the most importantly, the low efficiency of crossing the intact BBB, leading to the difficulty of achieving effective local drug concentration in the brain parenchyma.\nAccording to the various mechanisms of drug transport across BBB by nano carriers, only penetration of drug-carrier conjugates into the brain parenchyma via transcytosis or endocytosis exhibit suitability for all types of brain drugs. Therefore, to obtain a pratical delivery platform for brain drugs, it is suggested here that the development of a versatile delivery platform should focus on their capability as well as efficiency to be transcytosed or endocytosed.\nIn addition, the fate of drug carrier vehicles in the brain is a primary consideration. The first requirement for drug carrier vehicles is biocompatibility; compared with drug carrier vehicles targeting other organs, the accumulation of nano carriers in the brain parenchyma is a particular issue to be addressed in addition to toxicity and immunological response. Biodegradable nano carriers or nano carriers with the capability to penetrate out of the brain parenchyma across the intact BBB after drug release which can be removed by MPS are preferable. Unfourtunately, at present it is still unclear what effects of nano carrier’s accumulation in the brain parenchyma will be.\nLastly, to achieve the minimal effective drug concentration in brain parenchyma while the maximal safety drug concentration is not exceeded in other organs, the drug transport efficiency across the BBB by nano carriers should be elevated. From this viewpoint, it is necessary to explore new approaches facilitating endocytosis of nano carriers by the brain capillary endothelial cells, although the efficiency of drug accumulation in the brain parenchyma is not only determined by crossing\nBBB, but also by drug uploading and release profile which are relatively easy to be engineered."
    }, {
      "heading" : "Disclosure statement",
      "text" : "The authors report no conflicts of interest. The authors alone are responsible for the content and writing of this article."
    } ],
    "references" : [ {
      "title" : "Polymeric nanoparticles for the drug delivery to the central nervous system",
      "author" : [ "G Tosi", "L Costantino", "B Ruozi" ],
      "venue" : "Expert Opin Drug Deliv 2008;5:155–74",
      "citeRegEx" : "1",
      "shortCiteRegEx" : "1",
      "year" : 2008
    }, {
      "title" : "Nanotechnology for CNS delivery of bio-therapeutic agents",
      "author" : [ "L Shah", "S Yadav", "M. Amiji" ],
      "venue" : "Drug Deliv Transl Res",
      "citeRegEx" : "2",
      "shortCiteRegEx" : "2",
      "year" : 2013
    }, {
      "title" : "Nanotechnology for neurodegenerative disorders",
      "author" : [ "F Re", "M Gregori", "M. Masserini" ],
      "venue" : "Nanomed Nanotechnol Biol Med",
      "citeRegEx" : "3",
      "shortCiteRegEx" : "3",
      "year" : 2012
    }, {
      "title" : "Multifunctional nanocarriers for diagnostics, drug delivery and targeted treatment across blood-brain barrier: perspectives on tracking and neuroimaging",
      "author" : [ "S Bhaskar", "F Tian", "T Stoeger" ],
      "venue" : "Part Fibre Toxicol",
      "citeRegEx" : "4",
      "shortCiteRegEx" : "4",
      "year" : 2010
    }, {
      "title" : "Nano to micro delivery systems: targeting angiogenesis in brain tumors",
      "author" : [ "A Gilert", "M. Machluf" ],
      "venue" : "J Angiogenes Res",
      "citeRegEx" : "5",
      "shortCiteRegEx" : "5",
      "year" : 2010
    }, {
      "title" : "Nanocarriers’ entry into the cell: relevance to drug",
      "author" : [ "H Hillaireau", "P. Couvreur" ],
      "venue" : "delivery. Cell Mol Life Sci",
      "citeRegEx" : "6",
      "shortCiteRegEx" : "6",
      "year" : 2009
    }, {
      "title" : "Brain drug delivery systems",
      "author" : [ "X. Jiang" ],
      "venue" : "Pharm Res",
      "citeRegEx" : "7",
      "shortCiteRegEx" : "7",
      "year" : 2013
    }, {
      "title" : "Modern methods for delivery of drugs across the blood-brain barrier",
      "author" : [ "Y Chen", "L. Liu" ],
      "venue" : "Adv Drug Deliv Rev 2012;64:640–65",
      "citeRegEx" : "8",
      "shortCiteRegEx" : "8",
      "year" : 2012
    }, {
      "title" : "Nano-enabled delivery systems across the blood-brain barrier",
      "author" : [ "SR Hwang", "K. Kim" ],
      "venue" : "Arch Pharm Res",
      "citeRegEx" : "9",
      "shortCiteRegEx" : "9",
      "year" : 2014
    }, {
      "title" : "Nanomaterialmediated CNS delivery of diagnostic and therapeutic agents",
      "author" : [ "L Biddlestone-Thorpe", "N Marchi", "K Guo" ],
      "venue" : "Adv Drug Deliv Rev 2012;64:605–13",
      "citeRegEx" : "10",
      "shortCiteRegEx" : "10",
      "year" : 2012
    }, {
      "title" : "Nanoparticle technology for treatment of Parkinson’s disease: the role of surface phenomena in reaching the brain",
      "author" : [ "G Leyva-Gomez", "H Cortes", "JJ Magana" ],
      "venue" : "Drug Discov Today",
      "citeRegEx" : "11",
      "shortCiteRegEx" : "11",
      "year" : 2015
    }, {
      "title" : "Nanoparticle-based brain targeted delivery systems",
      "author" : [ "G Aditya", "H Anjali", "S. Vijaykumar" ],
      "venue" : "Biomol Res Ther 2013;2:e113",
      "citeRegEx" : "12",
      "shortCiteRegEx" : "12",
      "year" : 2013
    }, {
      "title" : "Nanoparticle-based targeted drug delivery",
      "author" : [ "Singh R", "Lillard JW Jr." ],
      "venue" : "Exp Mol Pathol",
      "citeRegEx" : "13",
      "shortCiteRegEx" : "13",
      "year" : 2009
    }, {
      "title" : "The potential for nanoparticle-based drug delivery to the brain: overcoming the blood-brain barrier",
      "author" : [ "E Barbu", "E Moln ar", "J Tsibouklis", "DC. G orecki" ],
      "venue" : "Expert Opin Drug Deliv",
      "citeRegEx" : "14",
      "shortCiteRegEx" : "14",
      "year" : 2009
    }, {
      "title" : "Nanoparticles for brain drug delivery. ISRN Biochemistry 2013;e238428",
      "author" : [ "M. Masserini" ],
      "venue" : null,
      "citeRegEx" : "15",
      "shortCiteRegEx" : "15",
      "year" : 2013
    }, {
      "title" : "Nanoparticles and the blood-brain barrier: advancing from in vitro models towards therapeutic significance",
      "author" : [ "DJ Mc Carthy", "M Malhotra", "AM O’Mahony" ],
      "venue" : "Pharm Res",
      "citeRegEx" : "16",
      "shortCiteRegEx" : "16",
      "year" : 2015
    }, {
      "title" : "Drug delivery strategies to enhance the permeability of the blood-brain barrier for treatment of glioma",
      "author" : [ "F Zhang", "CL Xu", "CM. Liu" ],
      "venue" : "Drug Des Dev Ther 2015;9:2089–100",
      "citeRegEx" : "17",
      "shortCiteRegEx" : "17",
      "year" : 2089
    }, {
      "title" : "Magnetic nanoparticles: design and characterization, toxicity and biocompatibility, pharmaceutical and biomedical applications",
      "author" : [ "LH Reddy", "JL Arias", "J Nicolas", "P. Couvreur" ],
      "venue" : "Chem Rev 2012;112:5818–978",
      "citeRegEx" : "18",
      "shortCiteRegEx" : "18",
      "year" : 2012
    }, {
      "title" : "Insight on the fate of CNS-targeted nanoparticles. Part I: Rab5-dependent cell-specific uptake and distribution",
      "author" : [ "A Vilella", "G Tosi", "AM Grabrucker" ],
      "venue" : "J Control Release",
      "citeRegEx" : "19",
      "shortCiteRegEx" : "19",
      "year" : 2014
    }, {
      "title" : "Nanoscale drug delivery systems and the blood-brain barrier",
      "author" : [ "R Alyautdin", "I Khalin", "MI Nafeeza" ],
      "venue" : "Int J Nanomedicine",
      "citeRegEx" : "20",
      "shortCiteRegEx" : "20",
      "year" : 2014
    }, {
      "title" : "Challenges in drug delivery to the brain: nature is against us",
      "author" : [ "S. Krol" ],
      "venue" : "J Control Release",
      "citeRegEx" : "21",
      "shortCiteRegEx" : "21",
      "year" : 2012
    }, {
      "title" : "Colloidal carriers and blood-brain barrier (BBB) translocation: a way to deliver drugs to the brain",
      "author" : [ "Garcia-GarciaE", "K Andrieux", "P. Gilb S Couvreur" ],
      "venue" : "Int J Pharm 2005;298:274–92",
      "citeRegEx" : "22",
      "shortCiteRegEx" : "22",
      "year" : 2005
    }, {
      "title" : "Challenges and opportunities in CNS delivery of therapeutics for neurodegenerative diseases",
      "author" : [ "BarchetTM AmijiMM" ],
      "venue" : "Expert Opin Drug Deliv 2009;6:211–25",
      "citeRegEx" : "23",
      "shortCiteRegEx" : "23",
      "year" : 2009
    }, {
      "title" : "The blood-brain barrier penetration and distribution of PEGylated fluorescein-doped magnetic silica nanoparticles in rat brain",
      "author" : [ "KuS", "F Yan", "Y Wang" ],
      "venue" : "Biochem Biophys Res",
      "citeRegEx" : "25",
      "shortCiteRegEx" : "25",
      "year" : 2010
    }, {
      "title" : "The targeted delivery of anticancer drugs to brain glioma by PEGylated oxidized multiwalled carbon nanotubes modified with angiopep-2",
      "author" : [ "RenJ", "S Shen", "D Wang" ],
      "venue" : "Biomaterials",
      "citeRegEx" : "26",
      "shortCiteRegEx" : "26",
      "year" : 2012
    }, {
      "title" : "Receptor-mediated delivery of magnetic nanoparticles across the blood-brain barrier",
      "author" : [ "QiaoR", "Q Jia", "S Huwel" ],
      "venue" : "ACS Nano 2012;6:3304–10",
      "citeRegEx" : "27",
      "shortCiteRegEx" : "27",
      "year" : 2012
    }, {
      "title" : "A facile approach for the delivery of inorganic nanoparticles into the brain by passing through the blood-brain barrier (BBB)",
      "author" : [ "YimYS", "ChoiJS", "KimGT" ],
      "venue" : null,
      "citeRegEx" : "28",
      "shortCiteRegEx" : "28",
      "year" : 2012
    }, {
      "title" : "Nanoformulation of antiretroviral drugs enhances their penetration across the blood brain barrier in mice",
      "author" : [ "FiandraL", "M Colombo", "S Mazzucchelli" ],
      "venue" : "Nanomed Nanotechnol Biol Med",
      "citeRegEx" : "29",
      "shortCiteRegEx" : "29",
      "year" : 2015
    }, {
      "title" : "Uptake and transport of superparamagnetic iron oxide nanoparticles through human brain capillary endothelial cells",
      "author" : [ "ThomsenLB", "Linemann T", "PondmanKM" ],
      "venue" : "ACS Chem Neurosci",
      "citeRegEx" : "30",
      "shortCiteRegEx" : "30",
      "year" : 2013
    }, {
      "title" : "68Ga-labeled gold glyconanoparticles for exploring blood-brain barrier permeability: preparation, biodistribution studies, and improved brain uptake via neuropeptide conjugation",
      "author" : [ "FrigellJ", "I Garc ıa", "V G omez-Vallejo" ],
      "venue" : "J Am Chem Soc 2014;136:449–57",
      "citeRegEx" : "31",
      "shortCiteRegEx" : "31",
      "year" : 2014
    }, {
      "title" : "Pharmacological and toxicological target organelles and safe use of single-walled carbon nanotubes as drug carriers in treating Alzheimer disease",
      "author" : [ "YangZ", "Y Zhang", "Y Yang" ],
      "venue" : "Nanomed Nanotechnol Biol Med",
      "citeRegEx" : "32",
      "shortCiteRegEx" : "32",
      "year" : 2010
    }, {
      "title" : "Solid lipid nanoparticles: production, characterization and applications",
      "author" : [ "K. MehnertW Mader" ],
      "venue" : "Adv Drug Deliv Rev 2001;47:165–96",
      "citeRegEx" : "33",
      "shortCiteRegEx" : "33",
      "year" : 2001
    }, {
      "title" : "Solid lipid nanoparticles for targeted brain drug delivery",
      "author" : [ "BlasiP", "S Giovagnoli", "A Schoubben" ],
      "venue" : "Adv Drug Deliv Rev 2007;59:454–77",
      "citeRegEx" : "34",
      "shortCiteRegEx" : "34",
      "year" : 2007
    }, {
      "title" : "Body distribution in mice of intravenously injected camptothecin solid lipid nanoparticles and targeting effect on brain",
      "author" : [ "YangS", "L Lu", "Y Cai" ],
      "venue" : "J Controlled Release",
      "citeRegEx" : "35",
      "shortCiteRegEx" : "35",
      "year" : 1999
    }, {
      "title" : "Solid lipid nanoparticles enhance the delivery of the HIV protease inhibitor, atazanavir, by a human brain endothelial cell line",
      "author" : [ "ChattopadhyayN", "Zastre J", "WongHL" ],
      "venue" : "Pharma Res",
      "citeRegEx" : "36",
      "shortCiteRegEx" : "36",
      "year" : 2008
    }, {
      "title" : "Brain-targeted solid lipid nanoparticles containing riluzole: preparation, characterization and biodistribution. Nanomedicine (Lond) 2010;5:25–32",
      "author" : [ "Bond ıML", "CraparoEF", "Giammona G Drago F" ],
      "venue" : null,
      "citeRegEx" : "37",
      "shortCiteRegEx" : "37",
      "year" : 2010
    }, {
      "title" : "bHydroxybutyric acid grafted solid lipid nanoparticles: A novel strategy to improve drug delivery to brain",
      "author" : [ "VenishettyVK", "R Samala", "R Komuravelli" ],
      "venue" : "Nanomed Nanotechnol Biol Med",
      "citeRegEx" : "38",
      "shortCiteRegEx" : "38",
      "year" : 2013
    }, {
      "title" : "Transferrin-conjugated solid lipid nanoparticles for enhanced delivery of quinine dihydrochloride to the brain",
      "author" : [ "Y Gupta", "A Jain", "SK. Jain" ],
      "venue" : "J Pharm Pharmacol",
      "citeRegEx" : "39",
      "shortCiteRegEx" : "39",
      "year" : 2007
    }, {
      "title" : "Poly (ethylene)-glycol conjugated solid lipid nanoparticles of noscapine improve biological half-life, brain delivery and efficacy in glioblastoma cells",
      "author" : [ "J Madan", "RS Pandey", "V Jain" ],
      "venue" : "Nanomed Nanotechnol Biol Med",
      "citeRegEx" : "40",
      "shortCiteRegEx" : "40",
      "year" : 2013
    }, {
      "title" : "Polymeric nanoparticles for drug delivery to the central nervous system",
      "author" : [ "T Patel", "J Zhou", "JM Piepmeier", "WM. Saltzman" ],
      "venue" : "Adv Drug Deliv Rev 2012;64:701–5",
      "citeRegEx" : "41",
      "shortCiteRegEx" : "41",
      "year" : 2012
    }, {
      "title" : "Drug delivery to the central nervous system by polymeric nanoparticles: what do we know",
      "author" : [ "J. Kreuter" ],
      "venue" : "Adv Drug Deliv Rev 2014;71:2–14",
      "citeRegEx" : "42",
      "shortCiteRegEx" : "42",
      "year" : 2014
    }, {
      "title" : "Quaternary ammonium betacyclodextrin nanoparticles for enhancing doxorubicin permeability across the in vitro blood-brain barrier",
      "author" : [ "ES Gil", "J Li", "H Xiao", "TL. Lowe" ],
      "venue" : "Biomacromolecules",
      "citeRegEx" : "43",
      "shortCiteRegEx" : "43",
      "year" : 2009
    }, {
      "title" : "b-cyclodextrin-poly(b-amino ester) nanoparticles for sustained drug delivery across the blood-brain barrier",
      "author" : [ "ES Gil", "L Wu", "TL. Xu L Lowe" ],
      "venue" : "Biomacromolecules",
      "citeRegEx" : "44",
      "shortCiteRegEx" : "44",
      "year" : 2012
    }, {
      "title" : "A relevant in vitro rat model for the evaluation of blood-brain barrier translocation of nanoparticles",
      "author" : [ "E Garcia-Garcia", "S Gil", "K Andrieux" ],
      "venue" : "Cell Mol Life Sci 2005;62:1400–8",
      "citeRegEx" : "45",
      "shortCiteRegEx" : "45",
      "year" : 2005
    }, {
      "title" : "Translocation of poly(ethylene glycol-co-hexadecyl)cyanoacrylate nanoparticles into rat brain endothelial cells: role of apolipoproteins in receptormediated endocytosis",
      "author" : [ "HR Kim", "K Andrieux", "S Gil" ],
      "venue" : "Biomacromolecules",
      "citeRegEx" : "46",
      "shortCiteRegEx" : "46",
      "year" : 2007
    }, {
      "title" : "Delivery of loperamide across the blood-brain barrier with polysorbate 80coated polybutylcyanoacrylate nanoparticles",
      "author" : [ "RN Alyautdin", "VE Petrov", "K Langer" ],
      "venue" : "Pharm Res",
      "citeRegEx" : "47",
      "shortCiteRegEx" : "47",
      "year" : 1997
    }, {
      "title" : "Nanoparticles, a drug carrier system to pass the blood-brain barrier, permit central analgesic effects of i.v. dalargin injections",
      "author" : [ "Schroder U Sabel BA" ],
      "venue" : "Brain Res",
      "citeRegEx" : "48",
      "shortCiteRegEx" : "48",
      "year" : 1996
    }, {
      "title" : "Nanoparticle technology for delivery of drugs across the blood-brain barrier",
      "author" : [ "U Schroeder", "P Sommerfeld", "S Ulrich", "BA. Sabel" ],
      "venue" : "J Pharm Sci 1998;87:1305–7",
      "citeRegEx" : "49",
      "shortCiteRegEx" : "49",
      "year" : 1998
    }, {
      "title" : "Poly(n-butylcyanoacrylate) nanoparticles coated with polysorbate 80 for the targeted delivery of rivastigmine into the brain to treat Alzheimer’s disease",
      "author" : [ "B Wilson", "MK Samanta", "K Santhi" ],
      "venue" : "Brain Res",
      "citeRegEx" : "50",
      "shortCiteRegEx" : "50",
      "year" : 2008
    }, {
      "title" : "Targeted delivery of tacrine into the brain with polysorbate 80-coated poly(nbutylcyanoacrylate) nanoparticles",
      "author" : [ "B Wilson", "MK Samanta", "K Santhi" ],
      "venue" : "Eur J Pharm Biopharm 2008;70:75–84",
      "citeRegEx" : "51",
      "shortCiteRegEx" : "51",
      "year" : 2008
    }, {
      "title" : "Nanotoxicity of poly(n-butylcyano-acrylate) nanoparticles at the blood-brain barrier, in human whole blood and in vivo",
      "author" : [ "M Kolter", "M Ott", "C Hauer" ],
      "venue" : "J Control Release",
      "citeRegEx" : "52",
      "shortCiteRegEx" : "52",
      "year" : 2015
    }, {
      "title" : "Nanoparticles enhance brain delivery of blood-brain barrier-impermeable probes for in vivo optical and magnetic resonance imaging",
      "author" : [ "RM Koffie", "CT Farrar", "LJ Saidi" ],
      "venue" : null,
      "citeRegEx" : "53",
      "shortCiteRegEx" : "53",
      "year" : 2011
    }, {
      "title" : "Trans-blood brain barrier delivery of dopamine-loaded nanoparticles reverses  JOURNAL OF DRUG TARGETING 25  functional deficits in Parkinsonian rats",
      "author" : [ "R Pahuja", "K Seth", "A Shukla" ],
      "venue" : "ACS Nano 2015;9:4850–71",
      "citeRegEx" : "54",
      "shortCiteRegEx" : "54",
      "year" : 2015
    }, {
      "title" : "Tissue inhibitor of matrix metalloproteinases-1 loaded poly(lactic-co-glycolic acid) nanoparticles for delivery across the blood-brain barrier",
      "author" : [ "M Chaturvedi", "Y Molino", "B Sreedhar" ],
      "venue" : "Int J Nanomed 2014;9:575–88",
      "citeRegEx" : "55",
      "shortCiteRegEx" : "55",
      "year" : 2014
    }, {
      "title" : "Intranasal and intravenous administration of octa-arginine modified poly(lactic-co-glycolic acid) nanoparticles facilitates central nervous system delivery of loperamide",
      "author" : [ "A O’Donnell", "A Moollan", "S Baneham" ],
      "venue" : "J Pharm Pharmacol",
      "citeRegEx" : "56",
      "shortCiteRegEx" : "56",
      "year" : 2014
    }, {
      "title" : "Shuttle-mediated nanoparticle delivery to the blood-brain barrier",
      "author" : [ "D Guarnieri", "A Falanga", "O Muscetti" ],
      "venue" : null,
      "citeRegEx" : "57",
      "shortCiteRegEx" : "57",
      "year" : 2013
    }, {
      "title" : "Brain delivery of NAP with PEGPLGA nanoparticles modified with phage display peptides",
      "author" : [ "J Li", "C Zhang" ],
      "venue" : "Pharm Res",
      "citeRegEx" : "58",
      "shortCiteRegEx" : "58",
      "year" : 2013
    }, {
      "title" : "Angiopep-conjugated poly(ethylene glycol)-co-poly(e-caprolactone) nanoparticles as dualtargeting drug delivery system for brain glioma",
      "author" : [ "H Xin", "X Jiang", "J Gu" ],
      "venue" : "Biomaterials",
      "citeRegEx" : "59",
      "shortCiteRegEx" : "59",
      "year" : 2011
    }, {
      "title" : "Transferrin-conjugated nanoparticles of poly(lactide)-D-alpha-tocopheryl polyethylene glycol succinate diblock copolymer for targeted drug delivery across the blood-brain barrier",
      "author" : [ "Gan CW Feng SS" ],
      "venue" : "Biomaterials",
      "citeRegEx" : "60",
      "shortCiteRegEx" : "60",
      "year" : 2010
    }, {
      "title" : "Transferrin- and transferring-receptor-antibody-modified nanoparticles enable drug delivery across the blood-brain barrier (BBB)",
      "author" : [ "U Karsten", "H Telli", "H Elisabeth", "K. Jorg" ],
      "venue" : "Eur J Pharm Biopharm 2009;71:251–6",
      "citeRegEx" : "61",
      "shortCiteRegEx" : "61",
      "year" : 2009
    }, {
      "title" : "Lactoferrin-conjugated PEG-PLA nanoparticles with improved brain delivery: In vitro and in vivo evaluations",
      "author" : [ "K Hu", "J Li", "Y Shen" ],
      "venue" : "J Control Release",
      "citeRegEx" : "62",
      "shortCiteRegEx" : "62",
      "year" : 2009
    }, {
      "title" : "Brain-targeted delivery of protein using chitosan- and RVG peptide-conjugated, pluronic-based nano-carrier",
      "author" : [ "JY Kim", "WI Choi", "YH Kim", "G. Tae" ],
      "venue" : "Biomaterials",
      "citeRegEx" : "63",
      "shortCiteRegEx" : "63",
      "year" : 2013
    }, {
      "title" : "A nanomedicine transports a peptide caspase-3 inhibitor across the bloodbrain barrier and provides neuroprotection",
      "author" : [ "H Karatas", "Y Aktas", "Y Gursoy-Ozdemir" ],
      "venue" : "J Neurosci 2009;29:13761–9",
      "citeRegEx" : "64",
      "shortCiteRegEx" : "64",
      "year" : 2009
    }, {
      "title" : "Development and brain delivery of chitosan-PEG nanoparticles functionalized with the monoclonal antibody OX26",
      "author" : [ "Y Aktas€ u", "M Yemisci", "K Andrieux" ],
      "venue" : "Bioconjug. Chem 2005;16:1503–11",
      "citeRegEx" : "65",
      "shortCiteRegEx" : "65",
      "year" : 2005
    }, {
      "title" : "Trimethylated chitosanconjugated PLGA nanoparticles for the delivery of drugs to the brain",
      "author" : [ "ZH Wang", "ZY Wang", "CS Sun" ],
      "venue" : "Biomaterials",
      "citeRegEx" : "66",
      "shortCiteRegEx" : "66",
      "year" : 2010
    }, {
      "title" : "Toward drug delivery into the brain: synthesis, characterization, and preliminary in vitro assessment of alkylglyceryl-functionalized chitosan nanoparticles",
      "author" : [ "E Molnar", "E Barbu", "CF Lien" ],
      "venue" : "Biomacromolecules",
      "citeRegEx" : "67",
      "shortCiteRegEx" : "67",
      "year" : 2010
    }, {
      "title" : "Synthesis of two AMPS-based polymerizable room temperature ionic liquids and swelling difference between their co-polymeric gels with HEMA",
      "author" : [ "X Yang", "Y Fang", "Z Li" ],
      "venue" : "ePolymers",
      "citeRegEx" : "68",
      "shortCiteRegEx" : "68",
      "year" : 2014
    }, {
      "title" : "Synthesis of the polymerizable room temperature ionic liquid AMPS-TEA and superabsorbency for organic liquids of its copolymeric gels with acrylamide",
      "author" : [ "T Weng", "J Guo", "X Li" ],
      "venue" : "Des Monomers Polym 2014;17:140–6",
      "citeRegEx" : "69",
      "shortCiteRegEx" : "69",
      "year" : 2014
    }, {
      "title" : "Synthesis, chloramphenicol uptake, and in vitro release of poly (AMPS–TEA-Co-AAm) gels with affinity for both water and alcohols",
      "author" : [ "T Weng", "J Guo", "X Li" ],
      "venue" : "Int J Polym Mater Polym Biomater 2014;63:73–9",
      "citeRegEx" : "70",
      "shortCiteRegEx" : "70",
      "year" : 2014
    }, {
      "title" : "Study on synthesis and chloramphenicol release of poly (2-hydroxyethylmethacrylate-co-acrylamide) hydrogels",
      "author" : [ "X Li", "Y. Cui" ],
      "venue" : "Chin J Chem Eng 2008;16:640–5",
      "citeRegEx" : "71",
      "shortCiteRegEx" : "71",
      "year" : 2008
    }, {
      "title" : "Invention of polysaccharide-based nanoparticles for enhancing drug permeability across the blood brain barrier",
      "author" : [ "Seok GE", "Lu LT" ],
      "venue" : null,
      "citeRegEx" : "72",
      "shortCiteRegEx" : "72",
      "year" : 2008
    }, {
      "title" : "Preparation and optimization of surface-treated methotrexate-loaded nanogels intended for brain delivery",
      "author" : [ "A Azadia", "M Hamidib", "MR Khoshayandc" ],
      "venue" : "Carbohydr Polym 2012;90:462–71",
      "citeRegEx" : "73",
      "shortCiteRegEx" : "73",
      "year" : 2012
    }, {
      "title" : "Methotrexate-loaded chitosan nanogels as ’Trojan Horses’ for drug delivery to brain: preparation and in vitro/in vivo characterization",
      "author" : [ "A Azadi", "M Hamidi", "MR. Rouini" ],
      "venue" : "Int J Biol Macromol 2013;62:523–30",
      "citeRegEx" : "74",
      "shortCiteRegEx" : "74",
      "year" : 2013
    }, {
      "title" : "Treatment of glioma by cisplatin-loaded nanogels conjugated with monoclonal antibodies against Cx43 and BSAT1",
      "author" : [ "VP Baklaushev", "NN Nukolova", "AS Khalansky" ],
      "venue" : "Drug Deliv 2015;22:276–85",
      "citeRegEx" : "75",
      "shortCiteRegEx" : "75",
      "year" : 2015
    }, {
      "title" : "Nanogels for oligonucleotide delivery to the brain",
      "author" : [ "SV Vinogradov", "EV Batrakova", "AV. Kabanov" ],
      "venue" : "Bioconjug Chem",
      "citeRegEx" : "76",
      "shortCiteRegEx" : "76",
      "year" : 2004
    }, {
      "title" : "Transferrin-modified c[RGDfK]paclitaxel loaded hybrid micelle for sequential blood-brain barrier penetration and glioma targeting therapy",
      "author" : [ "P Zhang", "L Hu", "Q Yin" ],
      "venue" : null,
      "citeRegEx" : "77",
      "shortCiteRegEx" : "77",
      "year" : 2012
    }, {
      "title" : "A new class of drug carriers: micelles of poly(oxyethylene)-poly(oxypropylene) block copolymers as microcontainers for drug targeting from blood in brain",
      "author" : [ "AV Kabanov", "EV Batrakova", "NS Melik-Nubarov" ],
      "venue" : "J Control Release",
      "citeRegEx" : "78",
      "shortCiteRegEx" : "78",
      "year" : 1992
    }, {
      "title" : "Polymeric micelles anchored with TAT for delivery of antibiotics across the blood-brain barrier",
      "author" : [ "L Liu", "SS Venkatraman", "Y Yang" ],
      "venue" : "Biopolym Peptide Sci 2008;90:617–23",
      "citeRegEx" : "79",
      "shortCiteRegEx" : "79",
      "year" : 2008
    }, {
      "title" : "Cyclic RGD-linked polymeric micelles for targeted delivery of platinum anticancer drugs to glioblastoma through the blood brain tumor barrier",
      "author" : [ "Y Miura", "T Takenaka", "K Toh" ],
      "venue" : "ACS Nano 2013;7:8583–92",
      "citeRegEx" : "80",
      "shortCiteRegEx" : "80",
      "year" : 2013
    }, {
      "title" : "Paclitaxel-loaded cholesterol-conjugated polyoxyethylene sorbitol oleate polymeric micelles for glioblastoma therapy across the blood-brain barrier",
      "author" : [ "C Li", "S Li", "T Tu" ],
      "venue" : "Polym Chem 2015;6:2740–51",
      "citeRegEx" : "81",
      "shortCiteRegEx" : "81",
      "year" : 2015
    }, {
      "title" : "Poly(ethylene glycol)-blockpoly(D,L-lactide acid) micelles anchored with angiopep-2 for brain-targeting delivery",
      "author" : [ "J Shen", "C Zhan", "C Xie" ],
      "venue" : "J Drug Target 2011;19:197–203",
      "citeRegEx" : "82",
      "shortCiteRegEx" : "82",
      "year" : 2011
    }, {
      "title" : "Surface modification of RGD-liposomes for selective drug delivery to monocytes/neutrophils in brain",
      "author" : [ "J Qin", "D Chen", "H Hu" ],
      "venue" : null,
      "citeRegEx" : "83",
      "shortCiteRegEx" : "83",
      "year" : 2007
    }, {
      "title" : "Theranostic liposomes loaded with quantum dots and apomorphine for brain targeting and bioimaging",
      "author" : [ "CJ Wen", "LW Zhang", "SA Al-Suwayeh" ],
      "venue" : "Int J Nanomed",
      "citeRegEx" : "84",
      "shortCiteRegEx" : "84",
      "year" : 2012
    }, {
      "title" : "A versatile liposome/cyclodextrin supramolecular carrier for drug delivery through the blood-brain barrier",
      "author" : [ "C Machut-Binkowski", "F Hapiot", "RO Cecchelli" ],
      "venue" : "J Incl Phenom Macrocycl Chem 2007;57:567–72",
      "citeRegEx" : "85",
      "shortCiteRegEx" : "85",
      "year" : 2007
    }, {
      "title" : "Glioma targeting and blood-brain barrier penetration by dual-targeting doxorubincin liposomes",
      "author" : [ "J Gao", "Q Lv", "L Li" ],
      "venue" : "Biomaterials",
      "citeRegEx" : "86",
      "shortCiteRegEx" : "86",
      "year" : 2013
    }, {
      "title" : "Lactoferrin-modified procationic liposomes as a novel drug carrier for brain delivery",
      "author" : [ "H Chen", "L Tang", "Y Qin" ],
      "venue" : "Eur J Pharm Sci 2010;40:94–102",
      "citeRegEx" : "87",
      "shortCiteRegEx" : "87",
      "year" : 2010
    }, {
      "title" : "Liposomal conjugates for drug delivery to the central nervous system. Pharmaceutics 2015;7:27–42",
      "author" : [ "F Helm", "G. Fricker" ],
      "venue" : null,
      "citeRegEx" : "88",
      "shortCiteRegEx" : "88",
      "year" : 2015
    }, {
      "title" : "Magnetic nanoformulation of azidothymidine 5’-triphosphate for targeted delivery across the blood-brain barrier",
      "author" : [ "ZM Saiyed", "NH Gandhi", "MPN. Nair" ],
      "venue" : "Int J Nanomed 2010;5:157–66",
      "citeRegEx" : "89",
      "shortCiteRegEx" : "89",
      "year" : 2010
    }, {
      "title" : "Imaging brain tumor by dendrimer-based optical/paramagnetic nanoprobe across the blood-brain barrier",
      "author" : [ "H Yan", "J Wang", "P Yi" ],
      "venue" : "Chem Commun (Camb.)",
      "citeRegEx" : "90",
      "shortCiteRegEx" : "90",
      "year" : 2011
    }, {
      "title" : "PEGylated poly(amidoamine) dendrimer-based dual-targeting carrier for treating brain tumors",
      "author" : [ "H He", "Y Li", "X Jia" ],
      "venue" : "Biomaterials",
      "citeRegEx" : "91",
      "shortCiteRegEx" : "91",
      "year" : 2011
    }, {
      "title" : "Methotrexate loaded polyether-copolyester dendrimers for the treatment of gliomas: enhanced efficacy and intratumoral transport",
      "author" : [ "RS Dhanikula", "A Argaw", "JF Bouchard", "P. Hildgen" ],
      "venue" : null,
      "citeRegEx" : "92",
      "shortCiteRegEx" : "92",
      "year" : 2008
    }, {
      "title" : "A dual-targeting nanocarrier based on poly(amidoamine) dendrimers conjugated with transferrin and tamoxifen for treating brain gliomas",
      "author" : [ "Y Li", "H He", "X Jia" ],
      "venue" : "Biomaterials",
      "citeRegEx" : "93",
      "shortCiteRegEx" : "93",
      "year" : 2012
    }, {
      "title" : "Gene delivery targeted to the brain using an Angiopep-conjugated polyethyleneglycolmodified polyamidoamine dendrimer",
      "author" : [ "W Ke", "K Shao", "R Huang" ],
      "venue" : "Biomaterials",
      "citeRegEx" : "94",
      "shortCiteRegEx" : "94",
      "year" : 2009
    }, {
      "title" : "The biodistribution of maltotriose modified poly(propylene imine) (PPI) dendrimers conjugated with fluorescein-proofs of crossing blood-brain-barrier",
      "author" : [ "A Janaszewska", "B Ziemba", "K Ciepluch" ],
      "venue" : "New J Chem 2012;36:350–3",
      "citeRegEx" : "95",
      "shortCiteRegEx" : "95",
      "year" : 2012
    }, {
      "title" : "Surface functionalisation regulates polyamidoamine dendrimer toxicity on bloodbrain barrier cells and the modulation of key inflammatory receptors on microglia",
      "author" : [ "A Bertero", "A Boni", "M Gemmi" ],
      "venue" : "Nanotoxicology",
      "citeRegEx" : "96",
      "shortCiteRegEx" : "96",
      "year" : 2014
    }, {
      "title" : "On the mechanism and dynamics of uptake and permeation of polyether-copolyester dendrimers across an in vitro blood-brain barrier model",
      "author" : [ "RS Dhanikula", "T Hammady", "P. Hildgen" ],
      "venue" : "J Pharm Sci 2009;98:3748–60",
      "citeRegEx" : "97",
      "shortCiteRegEx" : "97",
      "year" : 2009
    }, {
      "title" : "Evaluation of biotinylated PAMAM dendrimer toxicity in models of the blood brain barrier: a biophysical and cellular approach",
      "author" : [ "HA Bullen", "R Hemmer", "A Haskamp" ],
      "venue" : "J Biomater Nanobiotechnol",
      "citeRegEx" : "98",
      "shortCiteRegEx" : "98",
      "year" : 2011
    }, {
      "title" : "Coadministration of paclitaxel and curcumin in nanoemulsion formulations to overcome multidrug resistance in tumor cells",
      "author" : [ "S Ganta", "M. Amiji" ],
      "venue" : null,
      "citeRegEx" : "99",
      "shortCiteRegEx" : "99",
      "year" : 2009
    }, {
      "title" : "A review of multifunctional nanoemulsion systems to overcome oral and CNS drug delivery barriers",
      "author" : [ "S Ganta", "D Deshpande", "A. Korde" ],
      "venue" : "Mol Membr Biol",
      "citeRegEx" : "100",
      "shortCiteRegEx" : "100",
      "year" : 2010
    }, {
      "title" : "Cytotoxicity and apoptosis enhancement in brain tumor cells upon coadministration of paclitaxel and ceramide in nanoemulsion formulations",
      "author" : [ "A Desai", "T Vyas", "M. Amiji" ],
      "venue" : "J Pharm Sci 2008;97:2745–56",
      "citeRegEx" : "101",
      "shortCiteRegEx" : "101",
      "year" : 2008
    }, {
      "title" : "Improved oral bioavailability and brain transport of Saquinavir upon administration in novel nanoemulsion formulations",
      "author" : [ "Vyas TK", "Shahiwala A Amiji MM" ],
      "venue" : "Int J Pharm",
      "citeRegEx" : "102",
      "shortCiteRegEx" : "102",
      "year" : 2008
    }, {
      "title" : "The role of exosomes in the processing of proteins associated with neurodegenerative diseases",
      "author" : [ "LJ Vella", "RA Sharples", "RM Nisbet" ],
      "venue" : "Eur Biophys J 2008;37:323–32",
      "citeRegEx" : "103",
      "shortCiteRegEx" : "103",
      "year" : 2008
    }, {
      "title" : "Exosomes for targeted siRNA delivery across biological barriers",
      "author" : [ "SEL Andaloussi", "S Lakhal", "I M€ager", "MJA. Wood" ],
      "venue" : "Adv Drug Deliv Rev 2013;65:391–7",
      "citeRegEx" : "104",
      "shortCiteRegEx" : "104",
      "year" : 2013
    }, {
      "title" : "Exosome nanotechnology: An emerging paradigm shift in drug delivery: exploitation of exosome nanovesicles for systemic in vivo delivery of RNAi heralds new horizons for drug delivery across biological barriers",
      "author" : [ "Lakhal S", "Wood MJA" ],
      "venue" : "Bioessays",
      "citeRegEx" : "105",
      "shortCiteRegEx" : "105",
      "year" : 2011
    }, {
      "title" : "Exosomes as drug delivery vehicles for Parkinson’s disease therapy",
      "author" : [ "MJ Haney", "NL Klyachko", "Y Zhao" ],
      "venue" : "J Control Release",
      "citeRegEx" : "106",
      "shortCiteRegEx" : "106",
      "year" : 2015
    }, {
      "title" : "Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes",
      "author" : [ "L Alvarez-Erviti", "Y Seow", "HY Fang" ],
      "venue" : "Nature Biotechno 2011;29:341–7",
      "citeRegEx" : "107",
      "shortCiteRegEx" : "107",
      "year" : 2011
    }, {
      "title" : "Exosome delivered anticancer drugs across the blood-brain barrier for brain cancer therapy in Danio Rerio",
      "author" : [ "YangT", "P Martin", "B Fogarty" ],
      "venue" : "Pharm Res",
      "citeRegEx" : "108",
      "shortCiteRegEx" : "108",
      "year" : 2003
    }, {
      "title" : "Fluorescence nanoparticles ‘‘quantum dots’’ as drug delivery system and their toxicity: a review",
      "author" : [ "S Ghaderi", "B Ramesh", "AM. Seifalian" ],
      "venue" : "J Drug Target 2011;19:475–86",
      "citeRegEx" : "109",
      "shortCiteRegEx" : "109",
      "year" : 2011
    }, {
      "title" : "In vivo tumor-targeted fluorescence imaging using near-infrared non-cadmium quantum dots",
      "author" : [ "J Gao", "K Chen", "R Xie" ],
      "venue" : "Bioconjug Chem 2010;21:604–9",
      "citeRegEx" : "110",
      "shortCiteRegEx" : "110",
      "year" : 2010
    }, {
      "title" : "Quantum dots bearing lectinfunctionalized nanoparticles as a platform for in vivo brain imaging",
      "author" : [ "X Gao", "J Chen" ],
      "venue" : "Bioconjug. Chem 2008;19:2189–95",
      "citeRegEx" : "111",
      "shortCiteRegEx" : "111",
      "year" : 2008
    }, {
      "title" : "Organ distribution of quantum dots after intraperitoneal administration, with special reference to area-specific distribution in the brain",
      "author" : [ "S Kato", "K Itoh", "T Yaoi" ],
      "venue" : "Nanotechnology",
      "citeRegEx" : "112",
      "shortCiteRegEx" : "112",
      "year" : 2010
    }, {
      "title" : "Bioconjugated quantum rods as targeted probes for efficient transmigration across an in vitro blood-brain barrier",
      "author" : [ "G Xu", "KT Yong", "I Roy" ],
      "venue" : "Bioconjugate Chem 2008;19:1179–85",
      "citeRegEx" : "113",
      "shortCiteRegEx" : "113",
      "year" : 2008
    }, {
      "title" : "Biologically active core/shell nanoparticles self-assembled from cholesterol-terminated PEGTAT for drug delivery across the blood-brain barrier",
      "author" : [ "L Liu", "K Guo", "J Lu" ],
      "venue" : "Biomaterials",
      "citeRegEx" : "114",
      "shortCiteRegEx" : "114",
      "year" : 2008
    }, {
      "title" : "Rapid and effective labeling of brain tissue using TAT-conjugated CdS:Mn/ZnS quantum dots",
      "author" : [ "S Santra", "H Yang", "JT Stanley" ],
      "venue" : "Chem Commun",
      "citeRegEx" : "115",
      "shortCiteRegEx" : "115",
      "year" : 2005
    }, {
      "title" : "Synthesis of water-dispersible fluorescent, radio-opaque, and paramagnetic CdS:Mn/ZnS quantum dots: a multifunctional probe for bioimaging",
      "author" : [ "S Santra", "H Yang", "PH Holloway" ],
      "venue" : "J Am Chem Soc 2005;127:1656–7",
      "citeRegEx" : "116",
      "shortCiteRegEx" : "116",
      "year" : 2005
    }, {
      "title" : "Polymersomes: tough vesicles made from diblock copolymers",
      "author" : [ "BM Discher", "YY Won", "DS Ege" ],
      "venue" : "Science",
      "citeRegEx" : "117",
      "shortCiteRegEx" : "117",
      "year" : 1999
    }, {
      "title" : "Targeted delivery of nano-therapeutics for major disorders of the central nervous system",
      "author" : [ "H Gao", "Z Pang", "X. Jiang" ],
      "venue" : "Pharm Res",
      "citeRegEx" : "118",
      "shortCiteRegEx" : "118",
      "year" : 2013
    }, {
      "title" : "Polymeric nanocarriers for controlled and enhanced delivery of therapeutic agents to the CNS",
      "author" : [ "M Gagliardi", "G Bardi", "A. Bifone" ],
      "venue" : "Ther Deliv 2012;3:875–87",
      "citeRegEx" : "119",
      "shortCiteRegEx" : "119",
      "year" : 2012
    }, {
      "title" : "Molecular Trojan horses for blood-brain barrier drug delivery",
      "author" : [ "Pardridge WM" ],
      "venue" : "Curr Opin Pharmacol",
      "citeRegEx" : "120",
      "shortCiteRegEx" : "120",
      "year" : 2006
    }, {
      "title" : "Preparation and brain delivery property of biodegradable polymersomes conjugated with OX26",
      "author" : [ "Z Pang", "W Lu", "H Gao" ],
      "venue" : "J Control Release",
      "citeRegEx" : "121",
      "shortCiteRegEx" : "121",
      "year" : 2008
    }, {
      "title" : "Preparation, stability, and in vitro performance of vesicles made with diblock copolymers",
      "author" : [ "JCM Lee", "H Bermudez", "BM Discher" ],
      "venue" : null,
      "citeRegEx" : "122",
      "shortCiteRegEx" : "122",
      "year" : 2001
    }, {
      "title" : "Biomimetic pH sensitive polymersomes for efficient DNA encapsulation and delivery",
      "author" : [ "H Lomas", "I Canton", "S MacNeil" ],
      "venue" : "Adv Mater 2007;19:4238–43",
      "citeRegEx" : "123",
      "shortCiteRegEx" : "123",
      "year" : 2007
    }, {
      "title" : "Polymersomes: a new multi-functional tool for cancer diagnosis and therapy",
      "author" : [ "DH Levine", "PP Ghoroghchian", "J Freudenberg" ],
      "venue" : "Methods",
      "citeRegEx" : "124",
      "shortCiteRegEx" : "124",
      "year" : 2008
    }, {
      "title" : "A review of the formation and classification of amphiphilic block copolymer nanoparticulate structures: micelles, nanospheres, nanocapsules and polymersomes",
      "author" : [ "K Letchford", "H. Burt" ],
      "venue" : "Eur J Pharm Biopharm 2007;65:259–69",
      "citeRegEx" : "125",
      "shortCiteRegEx" : "125",
      "year" : 2007
    }, {
      "title" : "Brain delivery and cellular internalization mechanisms for transferrin conjugated biodegradable polymersomes",
      "author" : [ "Z Pang", "H Gao", "Y Yu" ],
      "venue" : "Int J Pharm 2011;415:284–92",
      "citeRegEx" : "126",
      "shortCiteRegEx" : "126",
      "year" : 2011
    }, {
      "title" : "Effect of lactoferrin- and transferrin-conjugated polymersomes in brain targeting: in vitro and in vivo evaluations",
      "author" : [ "H Gao", "Z Pang", "L Fan" ],
      "venue" : "Acta Pharmacol Sin 2010;31:237–43",
      "citeRegEx" : "127",
      "shortCiteRegEx" : "127",
      "year" : 2010
    }, {
      "title" : "Self-assembled polymersomes conjugated with lactoferrin as novel drug carrier for brain delivery",
      "author" : [ "Y Yu", "Z Pang", "W Lu" ],
      "venue" : "Pharm Res",
      "citeRegEx" : "128",
      "shortCiteRegEx" : "128",
      "year" : 2012
    }, {
      "title" : "Polymersomes conjugated with des-octanoyl ghrelin and folate as a BBB-penetrating cancer cell-targeting delivery system",
      "author" : [ "YC Chu", "CC Feng", "LC Fang" ],
      "venue" : "Biomaterials",
      "citeRegEx" : "129",
      "shortCiteRegEx" : "129",
      "year" : 2014
    }, {
      "title" : "Mechanism of polymeric nanoparticle-based drug transport across the blood-brain barrier (BBB)",
      "author" : [ "J. Kreuter" ],
      "venue" : "J Microencaps",
      "citeRegEx" : "130",
      "shortCiteRegEx" : "130",
      "year" : 2013
    }, {
      "title" : "Size-dependent endocytosis of nanoparticles",
      "author" : [ "S Zhang", "J Li", "G Lykotrafitis" ],
      "venue" : "Adv Mater Weinheim",
      "citeRegEx" : "131",
      "shortCiteRegEx" : "131",
      "year" : 2009
    }, {
      "title" : "Effects of particle size and surface coating on cellular uptake of polymeric nanoparticles for oral delivery of anticancer drugs",
      "author" : [ "Wina KY", "Feng SS" ],
      "venue" : "Biomaterials",
      "citeRegEx" : "132",
      "shortCiteRegEx" : "132",
      "year" : 2005
    }, {
      "title" : "Chitosan-based formulations for delivery of DNA and siRNA",
      "author" : [ "S Mao", "W Sun", "T. Kissel" ],
      "venue" : "Adv Drug Deliv Rev",
      "citeRegEx" : "133",
      "shortCiteRegEx" : "133",
      "year" : 2010
    }, {
      "title" : "Tight junction modulation by chitosan nanoparticles: Comparison with chitosan solution",
      "author" : [ "V Driton", "EH Ruth", "H Angeles" ],
      "venue" : "Int J Pharm 2010;400:183–93",
      "citeRegEx" : "134",
      "shortCiteRegEx" : "134",
      "year" : 2010
    }, {
      "title" : "Nanoparticle surface charges alter blood-brain barrier integrity and permeability",
      "author" : [ "PR Lockman", "JM Koziara", "RJ Mumper", "DD. Allen" ],
      "venue" : "J Drug Target 2004;12:635–41",
      "citeRegEx" : "135",
      "shortCiteRegEx" : "135",
      "year" : 2004
    }, {
      "title" : "Sodium dodecylsulphate induces a breach in the blood-brain barrier and enables a West Nile virus variant to penetrate into mouse brain",
      "author" : [ "D Kobiler", "S Lustig", "Y Gozes" ],
      "venue" : "Brain Res",
      "citeRegEx" : "136",
      "shortCiteRegEx" : "136",
      "year" : 1989
    }, {
      "title" : "Uptake and permeability studies of BBB-targeting immunoliposomes  using the hCMEC/D3 cell line",
      "author" : [ "E Markoutsa", "G Pampalakis", "A Niarakis" ],
      "venue" : "Eur J Pharm Biopharm 2011;77:265–74",
      "citeRegEx" : "137",
      "shortCiteRegEx" : "137",
      "year" : 2011
    }, {
      "title" : "In vitro assessment of alkylglyceryl-functionalized chitosan nanoparticles as permeating vectors for the blood-brain barrier",
      "author" : [ "CF Lien", "E Moln ar", "P Toman" ],
      "venue" : "Biomacromolecules",
      "citeRegEx" : "138",
      "shortCiteRegEx" : "138",
      "year" : 2012
    }, {
      "title" : "Analysis of plasma protein adsorption onto PEGylated nanoparticles by complementary methods: 2-DE, CE and protein Lab-on-chipVR system. Electrophoresis 2007;28:2252–61",
      "author" : [ "HR Kim", "K Andrieux", "C Delomenie" ],
      "venue" : null,
      "citeRegEx" : "139",
      "shortCiteRegEx" : "139",
      "year" : 2007
    }, {
      "title" : "Endothelial transport of macromolecules: transcytosis and endocytosis. A look from cell biology",
      "author" : [ "M Simionescu", "N. Simionescu" ],
      "venue" : "Cell Biol Rev 1991;25:1–78",
      "citeRegEx" : "140",
      "shortCiteRegEx" : "140",
      "year" : 1991
    }, {
      "title" : "CNS delivery via adsorptive transcytosis",
      "author" : [ "F Herv e", "N Ghinea", "JM. Scherrmann" ],
      "venue" : "AAPS J 2008;10:455–72",
      "citeRegEx" : "141",
      "shortCiteRegEx" : "141",
      "year" : 2008
    }, {
      "title" : "Brain permeable nanoparticles",
      "author" : [ "D Chopra", "M Gulati", "V Saluja" ],
      "venue" : "Recent Pat CNS Drug Discov 2008;3:216–25",
      "citeRegEx" : "142",
      "shortCiteRegEx" : "142",
      "year" : 2008
    }, {
      "title" : "Nanoparticulate systems for brain delivery of drugs",
      "author" : [ "J. Kreuter" ],
      "venue" : "Adv Drug Deliv Rev 2001;47:65–81",
      "citeRegEx" : "143",
      "shortCiteRegEx" : "143",
      "year" : 2001
    }, {
      "title" : "Nanotechnological advances for the delivery of CNS therapeutics",
      "author" : [ "HL Wong", "XY Wu", "R. Bendayan" ],
      "venue" : "Adv Drug Deliv Rev 2012;64:686–700",
      "citeRegEx" : "144",
      "shortCiteRegEx" : "144",
      "year" : 2012
    }, {
      "title" : "Nanotechnology-based drug delivery systems for targeting, imaging and diagnosis of neurodegenerative diseases",
      "author" : [ "Pehlivan SB" ],
      "venue" : "Pharm Res",
      "citeRegEx" : "145",
      "shortCiteRegEx" : "145",
      "year" : 2013
    }, {
      "title" : "The targeted delivery of cancer drugs across the blood-brain barrier: chemical modifications of drugs or drug-nanoparticles",
      "author" : [ "L. Juillerat-Jeanneret" ],
      "venue" : "Drug Discov Today",
      "citeRegEx" : "146",
      "shortCiteRegEx" : "146",
      "year" : 2008
    }, {
      "title" : "Polysorbate-stabilized solid lipid nanoparticles as colloidal carriers for intravenous targeting of drugs to the brain: comparison of plasma protein adsorption patterns",
      "author" : [ "G€  oppert TM", "M€  uller RH" ],
      "venue" : "J Drug Target 2005;13:179–87",
      "citeRegEx" : "147",
      "shortCiteRegEx" : "147",
      "year" : 2005
    }, {
      "title" : "Is there a clinical future for polymeric nanoparticles as brain-targeting drug delivery agents? Drug Discov Today 2012;17:367–78",
      "author" : [ "L Costantino", "D. Boraschi" ],
      "venue" : null,
      "citeRegEx" : "148",
      "shortCiteRegEx" : "148",
      "year" : 2012
    } ],
    "referenceMentions" : [ {
      "referenceID" : 7,
      "context" : "tricular administration [8,9], or noninvasive methods such as",
      "startOffset" : 24,
      "endOffset" : 29
    }, {
      "referenceID" : 8,
      "context" : "tricular administration [8,9], or noninvasive methods such as",
      "startOffset" : 24,
      "endOffset" : 29
    }, {
      "referenceID" : 14,
      "context" : "One approach is to modify the chemical structure of drugs; so far only one drug has been successful: the conversion of morphine to heroin [15,16].",
      "startOffset" : 138,
      "endOffset" : 145
    }, {
      "referenceID" : 15,
      "context" : "One approach is to modify the chemical structure of drugs; so far only one drug has been successful: the conversion of morphine to heroin [15,16].",
      "startOffset" : 138,
      "endOffset" : 145
    }, {
      "referenceID" : 16,
      "context" : "By coupling drugs with various brain nutrients or growth factors, such nutrients/growth factors-mediated delivery showed another promising approach to improve BBB permeability of brain drugs, as specific transporter proteins for brain nutrients/ growth factors on the membrane of brain capillary endothelial cells can also facilitate the transfer of some nutrient/growth factor–drug conjugates by means of transcytosis [17,18].",
      "startOffset" : 419,
      "endOffset" : 426
    }, {
      "referenceID" : 17,
      "context" : "By coupling drugs with various brain nutrients or growth factors, such nutrients/growth factors-mediated delivery showed another promising approach to improve BBB permeability of brain drugs, as specific transporter proteins for brain nutrients/ growth factors on the membrane of brain capillary endothelial cells can also facilitate the transfer of some nutrient/growth factor–drug conjugates by means of transcytosis [17,18].",
      "startOffset" : 419,
      "endOffset" : 426
    }, {
      "referenceID" : 18,
      "context" : "Nanomaterials are submicrometre objects that behave as a whole unit in terms of their transport and properties; it has been found that nanomaterials can internalize into most cells (including brain capillary endothelial cells) by means of normal endocytosis and transcytosis due to ‘‘nano effects’’ as a result of their small size [19].",
      "startOffset" : 331,
      "endOffset" : 335
    }, {
      "referenceID" : 23,
      "context" : "With high surface area, large pore volume, good biocompatibility and ease of functionalization, mesoporous silica nanoparticles have been conjugated with poly(ethylene glycol) (PEG) for BBB penetration as a result of their improved hydrophilicity, the eliminated aggregation in the blood stream, as well as the minimized clearance by the reticuloendothelial system (RES) [25].",
      "startOffset" : 371,
      "endOffset" : 375
    }, {
      "referenceID" : 24,
      "context" : "Oxidized multiwalled carbon nanotubes (O-MWNTs) uploaded with DOX have been conjugated with PEG and angiopep-2; the results of intracellular tracking in vitro and fluorescence imaging in vivo demonstrated that the combination of O-MWNTs-PEG and angiopep-2 constituted an ideal dual targeting drug delivery system for both BBB and glioma cells [26].",
      "startOffset" : 343,
      "endOffset" : 347
    }, {
      "referenceID" : 25,
      "context" : "It has been found that the PEG coating favors the transfer of the underlying Fe3O4 nanoparticles across the intact BBB model, while Lf-conjugated Fe3O4 nanoparticles exhibited an enhanced ability to cross the BBB in comparison with the PEGcoated Fe3O4 nanoparticles [27].",
      "startOffset" : 266,
      "endOffset" : 270
    }, {
      "referenceID" : 26,
      "context" : "Free cationic serum albumin can enter the brain via an adsorptive-transcytosis mechanism; and likewise, it has shown that magnetic nanoparticles of MnFe2O4 surfacely coated with crosslinked serum albumin demonstrated the capability of BBB permeability without any breakdown [28].",
      "startOffset" : 274,
      "endOffset" : 278
    }, {
      "referenceID" : 27,
      "context" : "Other surface coatings, such as poly(isobutylene-alt-1-tetradecene-maleic anhydride) (PMA), also facilitate BBB penetration of iron oxide nanoparticles uploaded with therapeutic molecules [29].",
      "startOffset" : 188,
      "endOffset" : 192
    }, {
      "referenceID" : 28,
      "context" : "It has been found that superparamagnetic iron oxide nanoparticles (SPIONs) composed of magnetite (Fe3O4) and maghemite (c-Fe2O3) can pass through human brain microvascular endothelial cells facilitated by an external magnet, which showed the magnetic force-mediated dragging of SPIONs through the BBB may denote a novel mechanism for the delivery of drugs to the brain [30].",
      "startOffset" : 369,
      "endOffset" : 373
    }, {
      "referenceID" : 29,
      "context" : "Other inorganic nanoparticles, such as gold nanoparticles (GNPs), have also been investigated for drug transport across the intact BBB [31].",
      "startOffset" : 135,
      "endOffset" : 139
    }, {
      "referenceID" : 30,
      "context" : "Although all research results showed inorganic nanoparticles are promising carrier vehicles to deliver drugs into brain, the issues of potential toxicity as a result of nondegradability and drug delivery efficiency still need to be addressed [32].",
      "startOffset" : 242,
      "endOffset" : 246
    }, {
      "referenceID" : 31,
      "context" : "Solid lipid nanoparticles (SLNs) are nano-sized dispersions of biocompatible lipids, such as triglycerides, fatty acids or waxes, stabilized by surfactants possessing HLB (hydrophile–lipophile balance) values lower than 12 [33,34].",
      "startOffset" : 223,
      "endOffset" : 230
    }, {
      "referenceID" : 32,
      "context" : "Solid lipid nanoparticles (SLNs) are nano-sized dispersions of biocompatible lipids, such as triglycerides, fatty acids or waxes, stabilized by surfactants possessing HLB (hydrophile–lipophile balance) values lower than 12 [33,34].",
      "startOffset" : 223,
      "endOffset" : 230
    }, {
      "referenceID" : 33,
      "context" : "3 mV exhibited higher drug concentration in the brain, heart and reticuloendothelial cells containing organs after intravenous injection in comparison to free camptothecin, which indicated that it was possible for the SLNs to cross the BBB [35].",
      "startOffset" : 240,
      "endOffset" : 244
    }, {
      "referenceID" : 34,
      "context" : "SLNs made from stearic acid stabilized with pluronicVR F68 showed the possibility to effectively deliver atazanavir to human brain endothelial cells in vitro [36].",
      "startOffset" : 158,
      "endOffset" : 162
    }, {
      "referenceID" : 35,
      "context" : "In vivo test in rats also showed that riluzole-uploaded SLNs exhibited a higher capability to carry the drug into the brain [37].",
      "startOffset" : 124,
      "endOffset" : 128
    }, {
      "referenceID" : 36,
      "context" : "Docetaxel-loaded SLNs have been prepared from monostearin, vitamin E and soya lecithin, followed by surface modification with stearylamine–betreliesoxybutyric acid (HBA, a ketone body and substrate for monocarboxylic acid transporter which is expressed on BBB) conjugate, for drug transport across the intact BBB [38].",
      "startOffset" : 313,
      "endOffset" : 317
    }, {
      "referenceID" : 37,
      "context" : "SLNs [39]; it has also been demonstrated that poly(ethylene glycol)grafted SLNs made from stearate using egg phosphatidyl choline and sodium glycocholate as surfactants uploaded with noscapine can improve drug accumulation in mice brain tissue [40].",
      "startOffset" : 5,
      "endOffset" : 9
    }, {
      "referenceID" : 38,
      "context" : "SLNs [39]; it has also been demonstrated that poly(ethylene glycol)grafted SLNs made from stearate using egg phosphatidyl choline and sodium glycocholate as surfactants uploaded with noscapine can improve drug accumulation in mice brain tissue [40].",
      "startOffset" : 244,
      "endOffset" : 248
    }, {
      "referenceID" : 39,
      "context" : "According to the drug-loading methods, therapeutic moleculesuploaded polymeric nanoparticles can form nanospheres (drugs are uploaded throughout or just onto the surface of the polymeric matrix) or nanocapsules (drugs are surrounded by a polymeric shell) that are thermodynamically stable [41].",
      "startOffset" : 289,
      "endOffset" : 293
    }, {
      "referenceID" : 40,
      "context" : "As a result of the diversity of polymers, polymeric nanoparticles can be designed to achieve desired properties, such as controlled and/or sustained drug release profile, as well as allowing drug release at the targeted site over a period of time [42].",
      "startOffset" : 247,
      "endOffset" : 251
    }, {
      "referenceID" : 41,
      "context" : "Uploaded with DOX, QA-CD nanoparticles showed permeability across the in vitro BBB by means of endocytosis [43].",
      "startOffset" : 107,
      "endOffset" : 111
    }, {
      "referenceID" : 42,
      "context" : "DOX-uploaded nanoparticles of bcyclodextrin crosslinked with b-amino ester also showed biocompatibility and permeability in an in vitro BBB model without impairing the integrity of the barrier [44].",
      "startOffset" : 193,
      "endOffset" : 197
    }, {
      "referenceID" : 43,
      "context" : "Another synthetic polymer, namely poly(MePEG2000cyanoacrylate-co-hexadecylcyanoacrylate) (PEG-PHDCA), demonstrated the capacity of their nanoparticles to reach the rat central nervous system (CNS) after intravenous injection [45].",
      "startOffset" : 225,
      "endOffset" : 229
    }, {
      "referenceID" : 44,
      "context" : "In contrast, polyhexadecylcyanoacrylate (PHDCA) nanoparticles did not penetrate across the BBB as a result of less adsorbed apolipoprotein E (ApoE) as well as apolipoprotein B-100 (ApoB-100) than PEG-PHDCA nanoparticles, which demonstrated that the involvement of apolipoproteins played an important role in the brain transport of PEG-PHDCA nanoparticles [46].",
      "startOffset" : 355,
      "endOffset" : 359
    }, {
      "referenceID" : 50,
      "context" : "PBCA is a biodegradable and biocompatible polymer; PBCA nanoparticles showed hardly any cytotoxic or inflammatory effect at therapeutic concentrations and incubation times, and they did not induce nonspecific BBB disruption, but collaborate with plasma apolipoprotein E to facilitate BBB crossing [52,53].",
      "startOffset" : 297,
      "endOffset" : 304
    }, {
      "referenceID" : 51,
      "context" : "PBCA is a biodegradable and biocompatible polymer; PBCA nanoparticles showed hardly any cytotoxic or inflammatory effect at therapeutic concentrations and incubation times, and they did not induce nonspecific BBB disruption, but collaborate with plasma apolipoprotein E to facilitate BBB crossing [52,53].",
      "startOffset" : 297,
      "endOffset" : 304
    }, {
      "referenceID" : 52,
      "context" : "Research has shown that PLGA nanoparticle-delivered dopamine reduced its autoxidation-mediated toxicity in the brain and reversed neurochemical and neurobehavioral deficits in parkinsonian rats [54].",
      "startOffset" : 194,
      "endOffset" : 198
    }, {
      "referenceID" : 53,
      "context" : "Due to no significant opening of the BBB caused by uncoated as well as polysorbate 80 coated PLGA nanoparticles, polysorbate 80 coating can be used to enhance protein delivery of PLGA nanoparticles across the BBB [55].",
      "startOffset" : 213,
      "endOffset" : 217
    }, {
      "referenceID" : 54,
      "context" : "Surface-modified PLGA nanoparticles with octa-arginine (R8) showed a faster cell uptake compared with the control [56], while the fluorescent aminated polystyrene (PS) nanoparticles surfacely functionalized with gH625 (a viral fusion peptide derived from the glycoprotein gH of herpes simplex virus type I) via a covalent-binding procedure showed a greater uptake by brain endothelial cells than that of the PS nanoparticles without the peptide [57].",
      "startOffset" : 114,
      "endOffset" : 118
    }, {
      "referenceID" : 55,
      "context" : "Surface-modified PLGA nanoparticles with octa-arginine (R8) showed a faster cell uptake compared with the control [56], while the fluorescent aminated polystyrene (PS) nanoparticles surfacely functionalized with gH625 (a viral fusion peptide derived from the glycoprotein gH of herpes simplex virus type I) via a covalent-binding procedure showed a greater uptake by brain endothelial cells than that of the PS nanoparticles without the peptide [57].",
      "startOffset" : 445,
      "endOffset" : 449
    }, {
      "referenceID" : 56,
      "context" : "Modification with a motif of TGNYKALHPHNG (TGN) could facilitate BBB penetration of poly(ethylene glycol)poly(D,L-lactide-co-glycolide) (PEG-PLGA) nanoparticles, leading to significant higher cellular uptake and in vivo brain accumulation [58].",
      "startOffset" : 239,
      "endOffset" : 243
    }, {
      "referenceID" : 57,
      "context" : "Angiopep, a ligand targeting the low-density lipoprotein receptorrelated protein (LRP) which is overexpressed on the BBB and glioma cells, has been conjugated with poly(ethylene glycol)-poly(ecaprolactone) (PEG-PCL) nanoparticles [59].",
      "startOffset" : 230,
      "endOffset" : 234
    }, {
      "referenceID" : 58,
      "context" : "Tf conjugated nanoparticles of poly(lactide)-D-a-tocopheryl polyethylene glycol succinate (PLA-TPGS) diblock copolymer showed more efficiency than the bare PLATPGS nanoparticles in brain delivery [60], while human serum albumin (HSA) nanoparticles covalently coupled with Tf or transferrin receptor monoclonal antibodies (OX26 or R17217) also demonstrated the capacity to transport drugs across the intact BBB [61].",
      "startOffset" : 196,
      "endOffset" : 200
    }, {
      "referenceID" : 59,
      "context" : "Tf conjugated nanoparticles of poly(lactide)-D-a-tocopheryl polyethylene glycol succinate (PLA-TPGS) diblock copolymer showed more efficiency than the bare PLATPGS nanoparticles in brain delivery [60], while human serum albumin (HSA) nanoparticles covalently coupled with Tf or transferrin receptor monoclonal antibodies (OX26 or R17217) also demonstrated the capacity to transport drugs across the intact BBB [61].",
      "startOffset" : 410,
      "endOffset" : 414
    }, {
      "referenceID" : 60,
      "context" : "Lf, a mammalian cationic iron-binding glycoprotein belonging to the transferring family, consists of a polypeptide chain of about 690 amino acids folded into two globular lobes, when conjugated with poly(ethylene glycol)-poly(lactide) nanoparticles, significantly facilitates cell uptake of the nanoparticles [62].",
      "startOffset" : 309,
      "endOffset" : 313
    }, {
      "referenceID" : 61,
      "context" : "A pluronic-based nano carrier conjugated with both chitosan and a specific target peptide for brain (rabies virus glycoprotein; RVG29) was effective for brain targeting across the intact BBB [63].",
      "startOffset" : 191,
      "endOffset" : 195
    }, {
      "referenceID" : 62,
      "context" : "Chitosan nanospheres conjugated with an anti-mouse transferrin receptor monoclonal antibody (TfRMAb) that selectively recognizes the TfR type 1 on the cerebral vasculature clearly demonstrated the effectiveness of bringing active peptides to the brain [64].",
      "startOffset" : 252,
      "endOffset" : 256
    }, {
      "referenceID" : 63,
      "context" : "Chitosan nanospheres conjugated with poly(ethylene glycol) (PEG) bearing the OX26 monoclonal antibody whose affinity for the transferrin receptor (TfR) may trigger receptor-mediated transport across the BBB successfully translocated into the brain tissue after intravenous administration [65].",
      "startOffset" : 288,
      "endOffset" : 292
    }, {
      "referenceID" : 64,
      "context" : "carbodiimide-mediated link, the resulted nanoparticles exhibited negligible cytotoxicity and enhanced brain uptake following intravenous administration compared with PLGA nanoparticles without TMC conjugation [66].",
      "startOffset" : 209,
      "endOffset" : 213
    }, {
      "referenceID" : 65,
      "context" : "During in vitro tests using a mouse-brain endothelial cell model, the efficient cellular uptake of these nanoparticles has demonstrated and identified butylglyceryl chitosan and butylglyceryl N,N,N-trimethyl chitosan as promising materials for the formulation of nanoparticles that could act as drug carriers into the brain [67].",
      "startOffset" : 324,
      "endOffset" : 328
    }, {
      "referenceID" : 66,
      "context" : "Gels are physically or chemically crosslinked three-dimensional (3D) polymeric networks that swell in certain liquids with compatible interfacial energies, and the swollen networks can retain a large amount of absorbed liquids [68].",
      "startOffset" : 227,
      "endOffset" : 231
    }, {
      "referenceID" : 67,
      "context" : "Both aqueous and organic liquids can be supporting media of polymeric gels, leading to the formation of hydrogels and organic gels, respectively [69].",
      "startOffset" : 145,
      "endOffset" : 149
    }, {
      "referenceID" : 68,
      "context" : "With good biocompatibility as a result of their relatively high water content, as well as the possibility of pharmaceutical molecules to diffuse into (drug loading) and out of (drug release), the swollen polymeric networks, hydrogels have been widely investigated for drug delivery [70,71].",
      "startOffset" : 282,
      "endOffset" : 289
    }, {
      "referenceID" : 69,
      "context" : "With good biocompatibility as a result of their relatively high water content, as well as the possibility of pharmaceutical molecules to diffuse into (drug loading) and out of (drug release), the swollen polymeric networks, hydrogels have been widely investigated for drug delivery [70,71].",
      "startOffset" : 282,
      "endOffset" : 289
    }, {
      "referenceID" : 70,
      "context" : "It has been reported that nanogels with surface charge exhibited better internalization property on cell membrane than neutral ones; Gil and Lowe synthesized polysaccharide-based nanogels containing poly(b-amino ester) and b-cyclodextrin for transporting doxorubicin and insulin across the BBB, such cationic nanogels enhanced the permeability of insulin across the in vitro BBB model by 20% [72].",
      "startOffset" : 392,
      "endOffset" : 396
    }, {
      "referenceID" : 71,
      "context" : "prepared nanogels loaded with methotrexate (MTX) via an ionic gelation process using chitosan and sodium tripolyphosphate (TPP) as raw materials, the surfaces of the MTX-loaded nanogels were modified with polysorbate 80 to improve brain drug delivery [73].",
      "startOffset" : 251,
      "endOffset" : 255
    }, {
      "referenceID" : 72,
      "context" : "After intravenous administration, remarkably higher brain concentrations of methotrexate were achieved with the nanogel formulations in comparison to the free drug, but there were no significant differences between the surface-coated and uncoated nanogels [74].",
      "startOffset" : 256,
      "endOffset" : 260
    }, {
      "referenceID" : 73,
      "context" : "as crosslinkers, for the treatment of intracranial gliomas [75].",
      "startOffset" : 59,
      "endOffset" : 63
    }, {
      "referenceID" : 74,
      "context" : "brain also showed similar results [76].",
      "startOffset" : 34,
      "endOffset" : 38
    }, {
      "referenceID" : 75,
      "context" : "with a hydrophobic core and hydrophilic surface [77].",
      "startOffset" : 48,
      "endOffset" : 52
    }, {
      "referenceID" : 77,
      "context" : "PEG-b-Chol amphiphilic block copolymer [79].",
      "startOffset" : 39,
      "endOffset" : 43
    }, {
      "referenceID" : 82,
      "context" : "possibility of uploading drugs in the aqueous core, liposomes have been widely investigated for systemic delivery of therapeutics [84].",
      "startOffset" : 130,
      "endOffset" : 134
    }, {
      "referenceID" : 83,
      "context" : "By using surface coatings, such as poly(ethylene glycol) (PEGylated liposomes), the circulation time of liposomes in the body can be prolonged [85].",
      "startOffset" : 143,
      "endOffset" : 147
    }, {
      "referenceID" : 84,
      "context" : "For example, the lipid bilayer of a 3/7 cholesterol/dipalmitoylphosphatidylcholine mixture was coated with n-alkyldimethylammoniumcyclodextrins which host adamantoylglucose molecules as a result of the adamantoyl moieties being included in the cyclodextrin cavities; such liposomes showed a 5-fold improved ability to enter the BBB endothelial cells compared with the non-coated samples [86].",
      "startOffset" : 387,
      "endOffset" : 391
    }, {
      "referenceID" : 85,
      "context" : "Doxorubincin liposomes conjugated with both folate and transferrin (Tf) also showed effectiveness in penetrating the BBB and targeting brain tumors [87].",
      "startOffset" : 148,
      "endOffset" : 152
    }, {
      "referenceID" : 86,
      "context" : "When they touched brain capillary endothelial cells with the help of a brain-targeting ligand, Lf, they were changed into cationic liposomes [88].",
      "startOffset" : 141,
      "endOffset" : 145
    }, {
      "referenceID" : 87,
      "context" : "Liposomes conjugated with cationized bovine serum albumin showed similar results compared with sterically stabilized (PEGylated) liposomes without protein as well as liposomes conjugated with native bovine serum albumin [89].",
      "startOffset" : 220,
      "endOffset" : 224
    }, {
      "referenceID" : 88,
      "context" : "Dendrimers are monodisperse symmetric macromolecules that comprise a series of branching units around an inner core [90].",
      "startOffset" : 116,
      "endOffset" : 120
    }, {
      "referenceID" : 89,
      "context" : "With many reactive groups on the surface, the number of arms and surface groups exponentially increase with each generation [91].",
      "startOffset" : 124,
      "endOffset" : 128
    }, {
      "referenceID" : 90,
      "context" : "Combined with their nanometer size range, dendrimers are attractive carrier vehicles for drug delivery [92].",
      "startOffset" : 103,
      "endOffset" : 107
    }, {
      "referenceID" : 91,
      "context" : "Li et al have synthesized the fourth-generation poly(amidoamine) (PAMAM) dendrimers with transferrin (Tf) conjugated on the exterior and tamoxifen (TAM) encapsulated in the interior [93].",
      "startOffset" : 182,
      "endOffset" : 186
    }, {
      "referenceID" : 92,
      "context" : "Angiopep, a ligand targeting to the low-density lipoprotein receptor-related protein-1 (LRP1), has been conjugated with PAMAM dendrimers for effective brain-targeting gene delivery [94].",
      "startOffset" : 181,
      "endOffset" : 185
    }, {
      "referenceID" : 93,
      "context" : "Other research results also showed the capacity of targeting ligand conjugated dendrimers to cross the intact BBB [95,96].",
      "startOffset" : 114,
      "endOffset" : 121
    }, {
      "referenceID" : 94,
      "context" : "Other research results also showed the capacity of targeting ligand conjugated dendrimers to cross the intact BBB [95,96].",
      "startOffset" : 114,
      "endOffset" : 121
    }, {
      "referenceID" : 95,
      "context" : "For example, PAMAM dendrimers have been shown to be hemolytic and cytotoxic [97].",
      "startOffset" : 76,
      "endOffset" : 80
    }, {
      "referenceID" : 96,
      "context" : "Some research results also showed that biotinylated PAMAM dendrimers may prove to be more toxic compared to PAMAM dendrimers alone [98].",
      "startOffset" : 131,
      "endOffset" : 135
    }, {
      "referenceID" : 97,
      "context" : "Nanoemulsions are heterogenous dispersions of oil-in-water (O/W) or water-in-oil (W/O) formulations stabilized with surface-active agents, where diameter of the inner phase is reduced to nanometer length scale [99].",
      "startOffset" : 210,
      "endOffset" : 214
    }, {
      "referenceID" : 98,
      "context" : "The versatility of nanoemulsions is based on the different types of oils and surface modifiers that can be used [100].",
      "startOffset" : 112,
      "endOffset" : 117
    }, {
      "referenceID" : 99,
      "context" : "The nanoemulsions of pine-nut oil with the oil droplet size of approximately 200 nm in diameter have been formulated for the delivery of paclitaxel (PTX) and C6-ceramide (CER) to the brain [101]; it has been found that the O/W nanoemulsions can improve the cytotoxic effect in brain tumor cells.",
      "startOffset" : 189,
      "endOffset" : 194
    }, {
      "referenceID" : 100,
      "context" : "In another study, O/W nanoemulsions containing saquinavir (SQV), an anti-HIV protease inhibitor, have been developed by dissolving SQV in different types of edible oils rich in essential polyunsaturated fatty acids (PUFA), followed by emulsifying in water-containing surfactants LipoidVR -80 and deoxycholic acid [102].",
      "startOffset" : 313,
      "endOffset" : 318
    }, {
      "referenceID" : 101,
      "context" : "Exosomes are a kind of nano-sized membranous vesicle secreted by a number of cell types and can be isolated from conditioned cell media or bodily fluids such as urine and plasma [103].",
      "startOffset" : 178,
      "endOffset" : 183
    }, {
      "referenceID" : 102,
      "context" : "Once released from a cell, exosomes can fuze with membrane of another cell, transferring exosomal molecules from one cell to another [104].",
      "startOffset" : 133,
      "endOffset" : 138
    }, {
      "referenceID" : 103,
      "context" : "The uptake mechanism of exosomes is clathrin-mediated endocytosis followed by back fusion with the limiting membrane of the endosomes, allowing for the possibility of exosomes to cross the intact BBB [105].",
      "startOffset" : 200,
      "endOffset" : 205
    }, {
      "referenceID" : 104,
      "context" : "Being secreted by living cells in the body, exosomes are natural delivery vehicles with advantages of non-toxicity, minimal immune responses, and better stability in the circulatory system in contrast to established formulations [106].",
      "startOffset" : 229,
      "endOffset" : 234
    }, {
      "referenceID" : 105,
      "context" : "used selfderived dendritic cells for exosome production; targeting peptides for muscle and brain were used to functionalize the exosomes [107].",
      "startOffset" : 137,
      "endOffset" : 142
    }, {
      "referenceID" : 106,
      "context" : "isolated four types of exosomes from brain cell culture media for drug delivery, and found that exosome-delivered anticancer drugs crossed the intact BBB and entered into the brain [108].",
      "startOffset" : 181,
      "endOffset" : 186
    }, {
      "referenceID" : 107,
      "context" : "Quantum dots are a class of colloidal semiconductor nano crystals composed of a metalloid crystalline core (such as cadmium selenium) and an intermediate unreactive metallic shell (such as zinc sulfide) that shields the core [109].",
      "startOffset" : 225,
      "endOffset" : 230
    }, {
      "referenceID" : 108,
      "context" : "Such an inorganic nano material has high brightness, long-term photostability and size-tunable narrow emission spectra, which makes it a revolutionary imaging technology for diagnostic purposes (fluorescent probes) [110].",
      "startOffset" : 215,
      "endOffset" : 220
    }, {
      "referenceID" : 109,
      "context" : "The outer coating of quantum dots can be chemically functionalized with bioactive molecules that promote aqueous solubility and desired bioactivity, enable targeting of specific molecules, as well as carrying therapeutic molecules [111].",
      "startOffset" : 231,
      "endOffset" : 236
    }, {
      "referenceID" : 110,
      "context" : "It has been found that intraperitoneally administered QDs-cap in mice were delivered through systemic blood circulation into the brain as well as into the liver, spleen and kidney, which showed the possibility of such quantum dots to penetrate the BBB [112].",
      "startOffset" : 252,
      "endOffset" : 257
    }, {
      "referenceID" : 111,
      "context" : "It has been found that the migration rate of such Tf-conjugated QDs crossing the in vitro BBB model was concentration- and time-dependent after a systemic administration, which demonstrated a receptor-mediated transport mechanism [113].",
      "startOffset" : 230,
      "endOffset" : 235
    }, {
      "referenceID" : 112,
      "context" : "TAT, a cell membrane translocation peptide, has been successfully used to internalize nanoparticles [114].",
      "startOffset" : 100,
      "endOffset" : 105
    }, {
      "referenceID" : 113,
      "context" : "Research has shown that TAT-conjugated CdS:Mn/ZnS quantum dots can label the brain tissue within a few minutes after being intra-arterially delivered to a rat brain without manipulating the BBB; such TAT-conjugated quantum dots migrated beyond the endothelial cell line and reached the brain parenchyma [115,116].",
      "startOffset" : 303,
      "endOffset" : 312
    }, {
      "referenceID" : 114,
      "context" : "Research has shown that TAT-conjugated CdS:Mn/ZnS quantum dots can label the brain tissue within a few minutes after being intra-arterially delivered to a rat brain without manipulating the BBB; such TAT-conjugated quantum dots migrated beyond the endothelial cell line and reached the brain parenchyma [115,116].",
      "startOffset" : 303,
      "endOffset" : 312
    }, {
      "referenceID" : 115,
      "context" : "Polymersomes are a nanometer-sized vesicular system with a bilayered membrane which is composed of amphiphilic block copolymers [117].",
      "startOffset" : 128,
      "endOffset" : 133
    }, {
      "referenceID" : 12,
      "context" : "Usually, amphiphilic block copolymers with a hydrophilic fraction of 35 ± 10% will aggregate to form polymersomes [13,118].",
      "startOffset" : 114,
      "endOffset" : 122
    }, {
      "referenceID" : 116,
      "context" : "Usually, amphiphilic block copolymers with a hydrophilic fraction of 35 ± 10% will aggregate to form polymersomes [13,118].",
      "startOffset" : 114,
      "endOffset" : 122
    }, {
      "referenceID" : 117,
      "context" : "Polymersomes enclose an aqueous solution in the core, which is useful for encapsulation and delivery of hydrophilic drugs, while the membrane of copolymer aggregates bi-layer can be loaded with small hydrophobic drugs [119,120].",
      "startOffset" : 218,
      "endOffset" : 227
    }, {
      "referenceID" : 118,
      "context" : "Polymersomes enclose an aqueous solution in the core, which is useful for encapsulation and delivery of hydrophilic drugs, while the membrane of copolymer aggregates bi-layer can be loaded with small hydrophobic drugs [119,120].",
      "startOffset" : 218,
      "endOffset" : 227
    }, {
      "referenceID" : 119,
      "context" : "Polymersomes are similar to liposome in structure; the main difference is that the external bi-layer is composed of amphiphilic copolymers with a molecular weight of up to 100 kDa, while the building block of liposome is in most cases naturally occurring phospholipid with a molecular weight below 1 kDa [121,122].",
      "startOffset" : 304,
      "endOffset" : 313
    }, {
      "referenceID" : 120,
      "context" : "Polymersomes are similar to liposome in structure; the main difference is that the external bi-layer is composed of amphiphilic copolymers with a molecular weight of up to 100 kDa, while the building block of liposome is in most cases naturally occurring phospholipid with a molecular weight below 1 kDa [121,122].",
      "startOffset" : 304,
      "endOffset" : 313
    }, {
      "referenceID" : 121,
      "context" : "With regard to the use of building blocks with high molecular weight, the membrane of polymersomes is thicker than that of liposome, providing a higher durable physical barrier that protects the enclosed drugs [123].",
      "startOffset" : 210,
      "endOffset" : 215
    }, {
      "referenceID" : 122,
      "context" : "When used for drug delivery, the more robust and therefore less leaky membrane of polymersome can improve circulation time and prevent uncontrolled release of drugs [124,125].",
      "startOffset" : 165,
      "endOffset" : 174
    }, {
      "referenceID" : 123,
      "context" : "When used for drug delivery, the more robust and therefore less leaky membrane of polymersome can improve circulation time and prevent uncontrolled release of drugs [124,125].",
      "startOffset" : 165,
      "endOffset" : 174
    }, {
      "referenceID" : 124,
      "context" : "Pang et al synthesized biodegradable poly(ethyleneglycol)-poly(ecaprolactone) (PEG-PCL) and used the block copolymer to prepare polymersomes (PO) by a nano precipitation method [126].",
      "startOffset" : 177,
      "endOffset" : 182
    }, {
      "referenceID" : 125,
      "context" : "Gao and coworkers prepared polymersomes of poly(butadiene-b-ethylene oxide) (PBD-PEO), poly(ethylene glycol-b-lactic acid) (PEG-PLA) and maleimide-PEG-PLA (Mal-PEG-PLA) (the weight ratio of PBD-PEO:PEGPLA:MAL-PEG-PLA was 7:2:1) using the film rehydration method [127], both Lf and Tf were used to functionalized the polymersomes (Lf-PO and Tf-PO) for brain targeting.",
      "startOffset" : 262,
      "endOffset" : 267
    }, {
      "referenceID" : 127,
      "context" : "port through the BBB and glioma cells targeting [129].",
      "startOffset" : 48,
      "endOffset" : 53
    }, {
      "referenceID" : 131,
      "context" : "capable of opening the tight junctions of the BBB [133,134], while",
      "startOffset" : 50,
      "endOffset" : 59
    }, {
      "referenceID" : 132,
      "context" : "capable of opening the tight junctions of the BBB [133,134], while",
      "startOffset" : 50,
      "endOffset" : 59
    }, {
      "referenceID" : 134,
      "context" : "induce a breach in the blood–brain barrier [136].",
      "startOffset" : 43,
      "endOffset" : 48
    }, {
      "referenceID" : 135,
      "context" : "A lipophilic surface of the nano carrier facilitates the adsorption; and a positive surface charge of the nano carrier promotes electrostatic interactions with the negative charges of endothelial surfaces which also facilitate the adsorption [137,138].",
      "startOffset" : 242,
      "endOffset" : 251
    }, {
      "referenceID" : 136,
      "context" : "A lipophilic surface of the nano carrier facilitates the adsorption; and a positive surface charge of the nano carrier promotes electrostatic interactions with the negative charges of endothelial surfaces which also facilitate the adsorption [137,138].",
      "startOffset" : 242,
      "endOffset" : 251
    }, {
      "referenceID" : 137,
      "context" : "Targeting ligands, such as the apolipoproteins, in plasma adsorbed on the surface of the nano carrier can target low-density lipoprotein receptors on the microvessel endothelial cells, which facilitates the adsorption [139].",
      "startOffset" : 218,
      "endOffset" : 223
    }, {
      "referenceID" : 138,
      "context" : "Endocytosis may occur by means of random uptake of soluble plasma molecules together with a bulk of plasma by caveolaes on the cells; such a process is independent of any interaction between the transported molecules and the caveolar vesicle membrane [140].",
      "startOffset" : 251,
      "endOffset" : 256
    }, {
      "referenceID" : 139,
      "context" : "Because the brain capillary endothelial cells are characterized by few caveolaes, while a high density of negatively charged and clathrin-coated pits through which drug–carrier conjugates can be be endocytosed, endocytosis of drug-carrier conjugates is mainly based on the adsorption of drug–carrier conjugates to the clathrincoated pit membrane [141].",
      "startOffset" : 346,
      "endOffset" : 351
    }, {
      "referenceID" : 145,
      "context" : "The relative high BBB permeability of acrylic nanoparticles has been attributed to the apolipoproteins in plasma adsorbed on the surface of the nano carrier targeting low-density lipoprotein receptors on the microvessel endothelial cells by some researchers [147].",
      "startOffset" : 258,
      "endOffset" : 263
    }, {
      "referenceID" : 146,
      "context" : "with nano carriers was less than 1% [148].",
      "startOffset" : 36,
      "endOffset" : 41
    } ],
    "year" : 2017,
    "abstractText" : "Effective therapy lies in achieving a therapeutic amount of drug to the proper site in the body and then maintaining the desired drug concentration for a sufficient time interval to be clinically effective for treatment. The blood–brain barrier (BBB) hinders most drugs from entering the central nervous system (CNS) from the blood stream, leading to the difficulty of delivering drugs to the brain via the circulatory system for the treatment, diagnosis and prevention of brain diseases. Several brain drug delivery approaches have been developed, such as intracerebral and intracerebroventricular administration, intranasal delivery and blood-to-brain delivery, as a result of transient BBB disruption induced by biological, chemical or physical stimuli such as zonula occludens toxin, mannitol, magnetic heating and ultrasound, but these approaches showed disadvantages of being dangerous, high cost and unsuitability for most brain diseases and drugs. The strategy of vector-mediated blood-to-brain delivery, which involves improving BBB permeability of the drug–carrier conjugate, can minimize side effects, such as being submicrometre objects that behave as a whole unit in terms of their transport and properties, nanomaterials, are promising carrier vehicles for direct drug transport across the intact BBB as a result of their potential to enter the brain capillary endothelial cells by means of normal endocytosis and transcytosis due to their small size, as well as their possibility of being functionalized with multiple copies of the drug molecule of interest. This review provids a concise discussion of nano carriers for drug transport across the intact BBB, various forms of nanomaterials including inorganic/solid lipid/polymeric nanoparticles, nanoemulsions, quantum dots, nanogels, liposomes, micelles, dendrimers, polymersomes and exosomes are critically evaluated, their mechanisms for drug transport across the BBB are reviewed, and the future directions of this area are fully discussed. ARTICLE HISTORY Received 2 November 2015 Revised 28 March 2016 Accepted 12 April 2016 Published online 20 May 2016",
    "creator" : "Arbortext Advanced Print Publisher 9.0.114/W"
  }
}